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Resumo 
O cancro é um problema de saúde crescente no mundo e é a segunda causa de morte 
depois das doenças cardíacas. De acordo com a Agência Internacional de Investigação 
em Cancro (IARC) existem atualmente mais de 10 milhões de casos de cancro por ano 
no mundo. 
Os produtos naturais oferecem oportunidades de inovação na descoberta de novos 
fármacos. Neste sentido, os compostos naturais isolados a partir de plantas medicinais, 
como potenciais fontes de novas drogas anticancerígenas, têm tido um interesse 
crescente. 
Os Óleos Essenciais (OEs) são sintetizados pelas plantas e têm sido estudados pelas 
suas inúmeras atividades biológicas, incluindo anticancerígena, anti-inflamatória, 
antimicrobiana, antiviral, antioxidante e repelente de insetos. 
Este estudo tem como objetivos determinar a eficácia de OEs de seis espécies de plantas 
das dunas de Peniche (Portugal), como potenciais agentes terapêuticos anticancerígenos 
em linhas celulares de cancro da mama (MCF7) e do colo-rectal (RKO), assim como 
perceber o mecanismo de ação destes OEs. 
Neste estudo, partes aéreas de Artemisia campestris subsp. maritima, Crithmum 
maritimum, Eryngium maritimum, Juniperus turbinata subsp. turbinata, Otanthus 
maritimus e Seseli tortuosum foram colhidas na praia da Consolação, em Peniche 
(Portugal), e os seus OEs isolados através de hidrodestilação. A composição química dos 
OEs foi investigada por cromatografia gasosa (GC) e por cromatografia gasosa com 
espetrofotometria de massa (GC-MS) e os compostos maioritários foram descritos para 
cada óleo. 
Para avaliar a atividade anticancerígena nas linhas celulares MCF7 e RKO, o método 
MTS (3- (4, 5-dimethyl- 2 -thiazolyl) - 2, 5-dyphenyl-2H-tetrazolium bromide) foi usado e a 
viabilidade celular avaliada, através de diluições sucessivas, a concentrações iniciais de 5 
µL/mL e 1 µL/mL, com diluição de 1:2 e 1:10, respetivamente, comparando com o 
controlo (DMSO). De todos os OEs testados, a atividade anticancerígena foi descrita, em 
ambas as linhas celulares, como observado pela diminuição da viabilidade/proliferação 
celular – exceto o OE Eryngium maritimum a uma concentração inicial de 5 µL/mL. 
 x 
Com o objetivo de avaliar o mecanismo biológico de ação dos OEs, foi realizado um 
western blot para marcadores relativos ao bloqueio do ciclo celular e apoptose (p53, p21 
e caspase 3 clivada), para Seseli tortuosum e Otanthus maritimus. Foi observado um 
aumento do nível proteína p53 nas células tratadas com estes OEs, sugerindo a indução 
de stress celular nas células cancerígenas testadas. No entanto, não foi observada 
caspase 3 clivada, sugerindo que a apoptose não terá sido a causa para a diminuição da 
viabilidade/proliferação celular observada. Foi ainda observado o aumento da expressão 
da p21 com os OEs selecionados, sugerindo que o tratamento com OE está associado ao 
bloqueio do ciclo celular. Para validar estas observações, a análise realizada por FACS, 
depois do tratamento indica um possível bloqueio do ciclo celular na fase G1. 
Concluindo, a concentração inicial de 5 µL/mL revelou ser muito tóxica para as linhas 
celulares testadas. No entanto, a uma concentração final de 1 µL/mL foi demonstrada 
uma diminuição da viabilidade/proliferação celular para todos os OEs. 
No estudo preliminar do mecanismo de ação dos OEs, foi demonstrado, face à presença 
da p21, que os óleos de Seseli tortuosum e Otanthus maritimus atuam bloqueando o ciclo 
celular. Para comprovar estes resultados, o FACS realizado (apenas no OE de Seseli 
tortuosum) revelou que este bloqueio pode ocorrer, pelo aumento da percentagem de 
células observadas, na fase G1. 
Estes resultados demonstram o interesse destes OEs de Peniche na procura de novos 
agentes quimo preventivos contra a progressão do cancro da mama e colo-rectal.   
 
Palavras-passe: Plantas Aromáticas, Óleo Essencial, Propriedades Anticancerígenas.
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Abstract 
Cancer is a growing health concern around the world and is the second leading cause of 
death after heart disease. According to the International Agency for Research on Cancer 
(IARC), there are now more than 10 million cases of cancer per year worldwide. 
Novel natural products offer opportunities for innovation in drug discovery. In this sense, 
natural compounds isolated from medicinal plants, as potential sources of novel 
anticancer drugs, have been of increasing interest.  
Essential Oils (EOs) are synthesised by plants and have been studied regarding their 
numerous biological activities, including anticancer, anti-inflammatory, antimicrobial, 
antiviral, antioxidant and insect repellent. 
This study aims to determine the efficacy of the EOs from six selected plant species from 
the dunes of Peniche (Portugal), as potential anticancer therapeutic agents in breast 
(MCF7) and colorectal (RKO) cancer cell lines, as also understand the mechanism of 
action of these EOs. 
In this work, aerial parts of Artemisia campestris subsp. maritima, Crithmum maritimum, 
Eryngium maritimum, Juniperus turbinata subsp. turbinata, Otanthus maritimus and Seseli 
tortuosum were harvested in Consolação beach, in Peniche (Portugal), and the EOs 
isolated by hidrodistillation. The chemical composition of EOs was investigated by gas 
chromatography (GC) and gas chromatography–mass spectrometry (GC–MS) and major 
compounds were reported for each EO. 
To evaluate anticancer activity in MCF7 and RKO cell lines, MTS (3-(4, 5-dimethyl-2-
thiazolyl)-2, 5-dyphenyl-2H-tetrazolium bromide) assay was carried out and cell viability 
was evaluated, through successive dilutions, at starting concentrations 5 µL/mL and 1 
µL/mL with a dilution 1:2 and 1:10, respectively, comparing to vehicle (DMSO). For all the 
EOs tested, anticancer activity was observed in both cell lines, as indicated by a decrease 
in cell viability/proliferation – except for Eryngium maritimum EO at starting concentration 
of 5 µL/mL. 
With the aim to evaluate the mechanism of biological effect of the EOs, a Western blot 
was carried out for markers of cell cycle arrest and apoptosis (p53, p21 and cleaved 
caspase 3), for Seseli tortuosum and Otanthus maritimus. Were observed an increase of 
p53 protein levels in cells treated with these EOs, suggesting that cellular stress was 
 xii 
induced in the cancer cells tested. However, cleaved caspase 3 was not observed, 
suggesting that apoptosis was not the cause for the observed decrease in cellular 
viability/proliferation. It was also observed the increased of p21 expression with the 
selected EOs, suggesting that EO treatment is associated with cell cycle arrest. To 
validate these observations, FACS analysis performed, indicating a possible G1 phase cell 
cycle arrest after treatment.  
In conclusion, the starting concentration 5 µL/mL revealed to be very toxic to the cell lines 
tested. However, at a starting concentration 1 µL/mL showed a decrease in cellular 
viability/proliferation for every EOs.  
In the preliminary study of the mechanism of action of EOs, was demonstrated, due to 
presence of p21, Seseli tortuosum and Otanthus maritimus EOs can act by arresting cell 
cycle. To comprove this results, the FACS performed (just for Seseli tortuosum EO) 
revealed this arrest may be occur, by the increase of percentage of cells observed, in G1 
phase. 
Our results show the interest of these EOs from Peniche in search of new chemo 
preventive agents against breast and colorectal cancer progression. 
 
Keywords: Aromatic Plants, Essential Oil, Anticancer Properties.
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1.1 Essential Oils   
1.1.1 Plant metabolic pathways   
Plants possess metabolic pathways through which sugars, amino acids, fats, nucleotides 
are synthesised (Evans 2002). These pathways constitute the plants primary metabolism 
since the compounds produced have an essential role in the plant metabolism and are 
universally present in all plants — these molecules are designated as primary metabolites 
(Azcon-Bieto & Talon 1996). 
Plants can also have other metabolic pathways that lead to the production of compounds 
characteristic of a taxonomic group (i.e. family, genus and species). These pathways con-
stitute the secondary metabolism and their products are designated as secondary me-
tabolites. The biosynthesis of these metabolites is restricted to specific stages of the de-
velopment and specialized cells of the plant, and can be induced by the stress caused by 
nutrient deficiency or by the attack by organisms (Azcon-Bieto & Talon 1996). 
Unlike primary metabolites, secondary metabolites do not have a direct role in the cells 
that produce them. Secondary metabolites are involved in functions such as providing 
characteristic odors, pungencies and colors; plant-plant relations and plant-animal interac-
tion, providing culinary, medicinal or poisonous properties to plants. Although the func-
tions of many secondary metabolites are already well known, for the greatest part of these 
the value to the plant is still unknown (Evans 2002). 
Essential oils (EOs) are secondary metabolites and they are produced in a wide range of 
plant species, called aromatic plants. 
 
1.1.2 Secretory structures in plants 
EOs are found in only 10% of the plant kingdom and can be synthetized by all plant 
organs, including buds, flowers, leaves, stems, twigs, seeds, fruits, roots and wood or 
bark (Gershenzon 1994; Ahmadi et al. 2002; Bezić et al. 2009; Djilani & Dicko 2010). 
Different organs can share the same kind of secretory structures or possess different 
types (Fahn 1979). These structures can be classified into six groups: secretory cells, 
osmophores, secretory cavities, secretory ducts, glandular trichomes (figure 1.1.2.1) and 
epidermal cells (Svoboda & Svoboda 2000; Fahn 1979). 
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Figure 1.1.2.1 – Schematic diagram of a glandular trichome illustrating the placement of this 
epidermal structures and the relationship of the disc of secretory cells to the stalk, basal cells and 
to the subcuticular storage space (Turner et al. 2014).  
 
Secretory cells are the simplest secretory structures comprising a single secretion-
containing cell where it is only the actual content that distinguishes it from adjacent non-
secretory cells (Svoboda & Svoboda 2000). This cell type is found in many different plant 
tissues, such as in the rhizome pith and cortex of ginger, and in the perisperm and embryo 
of nutmeg (Svoboda & Svoboda 2000). 
Osmophores are areas of flower tissues with secretory cells differing structurally from 
adjacent cells (e.g. isodiametric in orchids) (Fahn 1979). 
Secretory cavities are spherical structures that can be formed in two ways. In one 
mechanism, the parenchyma cells (thin-walled, relatively undifferentiated cells that may 
vary in structure and function) can separate one from another, leaving intercellular spaces 
called lumina or lacuna. The other, an actual cell can disintegrate and leave a cavity within 
the tissue (Fahn 1979; Svoboda & Svoboda 2000). These spaces are lined with secretory 
cells or an epithelium that produces the essential oils. In high oil-yielding plants, several 
layers of these secretory cells are formed. The cavities continually enlarge and some 
become filled with cells with thin, convoluted walls that also store the oil produced from 
within their plastids (a class of cytoplasmic organelles) (Fahn 1979; Azcon-Bieto & Talon 
1996; Svoboda & Svoboda 2000).   
Secretory ducts are elongated cavities. They can often branch to create a network 
extending from the roots through the stem to the leaves, flowers and fruits. They are 
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composed of an epithelium that surrounds a central cavity. Several predisposed cells 
within the parenchyma undergo asynchronous division and in doing so, expand the initial 
space in the middle, where the cells are adjacent, to form a cavity. Some of the cells 
forming the wall of the cavity will change into secretory epithelial cells. The oils are 
biosynthesized within their leucoplasts and move via the endoplasmic reticulum into the 
cavity. These cavities join up to form ducts (Fahn 1979; Svoboda & Svoboda 2000). 
Glandular trichomes are modified epidermal hairs and can be found covering leaves, 
stems, and even flower parts (Svoboda & Svoboda 2000). The secretory cells are 
attached by a single stem or basal cell in the epidermis. The outer surface of the gland is 
heavily cutinised (Fahn 1979). A cuticle, in which no pores or perforations are present, 
usually completely covers the trichome (Svoboda & Svoboda 2000). The EOs accumulate 
in subcuticular spaces and are thought to diffuse outwards through the cuticle (Fahn 
1979). The glandular cells differ from normal plant cells in that they have a very large 
nucleus and dense protoplasm that lacks a large central vacuole (Svoboda and Svoboda 
2000). There are numerous plasmodesmata (cytoplasmic threads running through cell 
walls, connecting cytoplasm of adjacent cells) across the walls of the gland cells, 
especially between the stalk cell and the collecting cell (Fahn 1979). In the very young 
gland the intracellular organization is almost identical to that of the adjacent cells, but as 
the secretory cells develop, complex changes occur (Svoboda & Svoboda 2000). The 
membrane system progressively degenerates and in the fully developed glands only a thin 
granular cytoplasm (the living cell parts within the membrane, except the nucleus) remains 
(Fahn 1979; Svoboda & Svoboda 2000). 
Secretory cells also occur in flower petals – for example in jasmine and rose. As in this 
cases glandular hairs and glandular trichomes are not present, the volatile oil diffuses 
through the epidermal cells and the cuticle to reach the atmosphere (Svoboda & 
Svoboda 2000).   
 
1.1.3 Chemical composition of essential oils 
Since ancient times, EOs have been recognised for their medicinal value and are 
considered very interesting and powerful natural plant products (Baris et al. 2006).  EOs 
continue to be of paramount importance until the present day (Margaris et al. 1982; 
Tisserand 1997). Recording findings in Mesopotamia, China, India, Persia and ancient 
Egypt show their uses for many treatments in various forms (Guenther 1948; Wei & 
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Shibamoto 2010). For example, in ancient Egypt, the population extracted oils by infusion 
for medicinal purposes (Burt 2004; Peeyush et al. 2011). 
EOs naturally occur in aromatic plants, which make these species very valuable. Among 
many other well-known families rich in species bearing EOs are Apiaceae, Asteraceae, 
Geraniaceae, Lamiaceae, Pinaceae, Solanaceae, Verbenaceae (Figueiredo et al. 1997; 
Ahmadi et al. 2002; Elias et al. 2003). 
According to the International Standard Organization on Essential Oils, ISO 9235 (1997) 
of the ISO/TC and the Portuguese Standard, NP 90 (1987) of the IPQ-CT 5, the definition 
of EO is restricted to the products obtained exclusively by distillation of plant material, with 
or without water steam, or by mechanical processes applied to the pericarp of fruits of the 
genus Citrus L. EOs are volatile, natural, complex compounds characterised by a strong 
odour. They are hydrophobic, soluble in alcohol, DMSO and methanol, non-polar or 
weakly polar solvents, waxes and oils (Gupta et al. 2010). EOs are limpid and rarely 
coloured, most are liquid and of lower density than water (Ciccarelli et al. 2008; Martín et 
al. 2010). Due to their molecular structures (presence of olefenic double bonds and 
functional groups such as hydroxyl, aldehyde, and ester) EOs are readily oxidizable by 
light, heat and air (Gershenzon 1994; Liolios et al. 2010; Djilani & Dicko 2010). 
Essential oils are very complex natural mixtures that can contain about 20-60 components 
at varied concentrations (Miguel 2010). They are composed by two or three major 
components at fairly high concentrations (20-70%), with other components present in 
trace amounts. Generally, these major components determine the biological properties of 
the EOs (Skaltsa et al. 2003; Sell 2006; Thomar 2011).  
These oils may comprise volatile compounds that have carbon, hydrogen, and oxygen as 
their building blocks. The major volatile constituents are: hydrocarbons, alcohols, acids, 
aldehydes, cyclic aldehydes, ketones, lactones, phenols, phenolic ethers, oxides and 
esters (Bakkali et al. 2008). These are subdivided into two categories: of terpenoid 
origin, for compounds composed almost exclusively of terpenes (monoterpenes, 
sesquiterpenes and diterpenes), and nonterpenoid origin, for compounds containing 
phenylpropanoid and aliphatic skeletons. Some compounds may also contain nitrogen 
(antharanilates, pyrazines) or sulphur (thiols, sulphides) (Bakkali et al. 2008; Baser & 
Demirci 2007; Kalemba & Wajs 2011). All of them are hydrocarbons and their oxygenated 
derivatives (Proença da Cunha et al. 2003). 
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Terpenoids (figure 1.1.3.1) are the most structurally varied class of plant natural products 
(Bakkali et al. 2008). In nature, they play significant roles in plant-environment 
interactions, plant-plant communication and plant-animal interactions (Pichersky & 
Gershenzon 2002). They are commercially important due to their wide application in a 
vast number of industrial products, such as flavouring agents, pharmaceuticals, perfumes, 
insecticides and anti-microbial agents (Martin et al. 2003).  
 
 
 
 
 
 
 
 
 
 
Figure 1.1.3.1 – Chemical structures of terpenoids (selected compounds of essential oils). 
Monoterpenes have a variety of structures, for example - Carbures, Alcohols, Aldeydes, Ketones, 
Esters and Ethers. The structures of the sesquiterpenes - Carbures, Alcohols, Ketones and 
Epoxides - are similar comparing to the monoterpenes (modified after Bakkali et al. 2008).  
 
Terpenes result from the condensation of the pentacarbonate unit, 2-methilbutadiene or 
isoprene (Dubey et al. 2003). For this reason they are also called isoprenoides. These are 
classified according to the isoprene units (five carbons) in their structure: hemiterpenes 
C5 (1 isoprene unit), monoterpenes C10 (2 isoprene units), sesquiterpenes C15 (3 
isoprene units), diterpenes C20 (4 isoprene units), sesterpenes C25 (5 isoprene units), 
triterpenes C30 (6 isoprene units), tetraterpenes C40 (8 isoprene units) and polyterpenes 
(C5) n (Dubey et al. 2003). Dimers and trimers of isoprene, monoterpenes with 10 
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carbons and sesquiterpenes with 15 carbons, respectively, are predominant in essential 
oils (Gershenzon & Kreis, 1999; Proença da Cunha et al. 2003). 
In higher plants, terpenes are synthesised via two isopentenyl diphosphate (IPP) 
generating pathways. Isopentenyl diphosphate (IPP) and dimethylallyldiphosphate 
(DMAPP) serve as universal precursors for the biosynthesis of terpenes. They are 
biosynthesised through the mevalonate (MVA) and the non-mevalonate or deoxyxylulose 
phosphate pathways (DXP) (Croteau 2000; Sangwan et al. 2001; Dubey et al. 2003; 
Baser & Demirci 2007) (Figure 1.1.3.2). 
 
Figure 1.1.3.2 – The two different terpenoid classes in the mitochondria and plastids , respectively 
(from Baser & Demirci 2007).  
 
Nonterpenoids or aromatic compounds (Figure 1.1.3.3) are derived from phenylpropane 
and occur less frequently than the terpenes. The biosynthetic pathways concerning 
terpenes and phenylpropanic derivatives generally are separated in plants but may 
coexist in some, with one major pathway taking over. Nonterpenoid compounds comprise: 
Aldeyde; alcohol, phenols, methoxy derivatives and methylene dioxy compounds (Bick & 
Lange 2003; Baser & Demirci 2007; Bakkali et al. 2008) 
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Nitrogenous or sulphured components such as glucosinolates or isothiocyanate 
derivatives (garlic and mustard oils) are also characteristic as secondary metabolites of 
diverse plants or of torrefied, grilled or roasted products (Bick & Lange 2003; Baser & 
Demirci 2007).  
 
Figure 1.1.3.3 – Chemical structures of non-terpenoids compounds (selected compounds of 
essential oils) (modified after Bakkali et al. 2008).  
 
 
1.1.4 Factors influencing the production and quality of essential oils 
The fragrance and chemical composition of essential oils may vary according to the geo-
climatic location and growing conditions (soil type, climate, altitude and amount of water 
available), season (before and after flowering), and time of day of harvesting (Djilani & 
Dicko 2010). Another important factor is the genetic composition of the plant. All these 
factors (genetic and epigenetic) influence the biochemical synthesis of EOs in a given 
plant (Bakkali et al. 2008; Adorjan & Buchbauer 2010). In this way, specimens from same 
species of plant can produce a similar essential oil but with different chemical 
composition, resulting in different therapeutic activities (Djilani & Dicko 2010). 
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1.1.5 Extraction techniques 
The two main industrial processes used to obtain EOs are distillation and expression. 
However, there are more methodologies to obtain other aromatic extracts from aromatic 
plants, such as extraction by solvents, and adsorption techniques (Lawrence 1995; Başer 
& Demirci 2007; Figueiredo et al. 2007; Proença da Cunha et al. 2003). 
The main method, at a laboratory scale that is used to obtain EOs from plant material is 
the distillation with water (hydrodistillation), using a Clevenger apparatus (figure 1.5.1.1). 
However, if not enough plant material is available to obtain the EOs by hydrodistillation, 
solvent extraction or solid phase micro-extraction can be used as alternative extraction 
processes to obtain a small amount of the volatile compounds and determine the chemical 
composition. 
 
1.1.5.1 Hydrodistillation  
The principle of this process is to boil a suspension of an aromatic plant material in water 
so that its vapour can be condensed. The oil, which is immiscible with the water, is then 
separated. In this extraction process, the plant material is always in direct contact with 
water. This technique has the advantage of only dragging volatile substances, and is 
simple and cheap (Lawrence 1995). 
The apparatus (figure 1.1.5.1.1) described in the Portuguese Pharmacopoeia (2005), for 
dosage of essential oils in aromatic plants comprises the following parts: (1) a suitable 
round-bottomed flask with a short, ground-glass neck having an internal diameter of about 
29 mm at the wide end, where the plants and the water boil; (2) a condenser assembly 
that closely fits the flask; (3) a suitable heating device, allowing a fine control; and (4) a 
vertical support with a horizontal ring covered with insulating material (Farmacopeia 
Portuguesa 2005). 
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Figure 1.1.5.1.1 – Clevenger apparatus. Dimensions are indicated in millimetres (Farmacopeia 
Portuguesa 2005). 
 
1.2 Biological Properties of Essential Oils 
Approximately 3000 EOs have been described known, 300 of which are commercially 
important especially for the pharmaceutical, agronomic, food, sanitary, cosmetic and 
perfume industries (Djilani & Dicko 2010). For example, d-limonene, geranyl acetate or d-
carvone are employed in perfumes, creams, soaps, as flavor additives for food, as 
fragrances for household cleaning products and as industrial solvents (Hajhashemi et al. 
2003; Perry et al. 2003). However, the information available on the estimation of precisely 
number EOs is scarce (Silva et al. 2003; Djilani & Dicko 2010).  
Essential oils are used in massage vegetable oil mixtures or added to baths but most 
frequently in aromatherapy (Perry et al. 2003). Importantly, EOs are also extremely useful 
as therapeutic agents for several pathologies. The use of EOs in medical applications has 
become very popular, both for the complex oil mixes, as well as the individual constituents 
as single compounds (Hajhashemi et al. 2003; Perry et al. 2003; Djilani & Dicko 2010).  
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Essential oils have been largely employed for their properties observed in nature, i.e. for 
their anti-nociceptive effect, insect repellent activity, antiviral activity, as well as other 
proprieties, such as antioxidant activity and anticancer activity. 
 
1.2.1 Antinociceptive Effect 
A nociceptor is a sensory receptor that responds to potentially damaging stimuli by 
sending nerve signals to the spinal cord and brain (Hucho & Levine 2007; Maham et al. 
2013). The antinociceptive effect is a reduction in pain sensitivity made within neurons 
when endorphin or a similar opium-containing substance combines with a receptor 
(Maham et al. 2013).  
Sousa and collaborators analysed the antinociceptive and anti-inflammatory effects of the 
EO extracted from Eremanthus erythropappus (DC.) McLeish (Asteraceae) leaves. In in 
vivo studies using mice, treatment with the Eremanthus EO led to a significant increase of 
the reaction time (reduction in pain sensitivity) after 30, 60 and 90 minutes of treatment, at 
doses of 200 mg/kg and 400 mg/kg (Sousa et al. 2008).  
In 2008, the antinociceptive activity of the volatile oils of Hyptis pectinataI L. Pois (Lamiae) 
genotypes were analysed by Arrigoni-Blank and co-workers (Arrigoni-Blank et al. 2008) 
The use of H. pectinata is very common in Brazilian folk medicine for the treatment of 
inflammations, bacterial infections and pain. Six genotypes of volatile oil were 
investigated. The main compounds of all genotypes are sesquiterpenes. In the models 
used, all genotypes showed antinociceptive effect, for both central and peripheral nervous 
system (Arrigoni-Blank et al. 2008). 
Takaki and colleagues investigated the anti-inflammatory and anti-nociceptive effects of 
Rosmarinus officinalis L. (Lamiaceae) EO in experiment in animal models (Takaki et al. 
2008). In this study, it was shown that Eos extracted from Rosmarinus officinalis, at a 
dose of 500 mg/kg, led to a significant reduction of the volume of pleural exudate and 
slightly decreased the number of cells that had migrated in treated animals, when 
compared with control animals (not treated) (Takaki et al. 2008). 
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1.2.2 Insect Repellent Activity 
Currently, the use of synthetic chemicals to control insects and arthropods raises several 
concerns related to the environment and human health. Therefore, there is a growing 
demand for alternative repellents or natural products. These products should possess 
good efficacy and be environmentally friendly (Nerio et al. 2010). Essential oils from 
several species have been extensively tested to assess their repellent and even 
insecticidal properties as a valuable natural source (Nerio et al. 2010). 
In 2007, Rajkumar and colleagues investigated the repellent effect of selected EO against 
the malaria fever mosquito Anopheles stephensi in mosquito cages (Rajkumar et al. 
2007). The five EOs tested were from Centella asiatica; Ipomoea cairica; Momordica 
charantia; Psidium guajava and Tridax procumbens. The oils were tested at three 
concentrations: 2, 4 and 6% (v/v). A dose-dependent effect was noticed and the highest 
concentration (6%) led to the highest repellent effect (Rajkumar et al. 2007). 
In a study looking at the repellent effects of catmint (Nepeta cataria L., Lamiaceae) oil 
formulations against black flies (Simulium decorum Walker) and mosquitoes (primarily 
Aedes intrudens Dyar) in Maine and Florida showed that tested all formulations led to 
protection against mosquitoes for more than 4 hours (Rajkumar et al. 2007). 
 
1.2.3 Antiviral Activity 
A virus is a small infectious particle (20-300 nm) that is able to infect cells of another living 
organism, in which it can replicate itself (Saddi et al. 2007). Viruses cannot reproduce on 
their own: a virus is composed of genes and a protein coat, and some have an envelope 
of fat that surrounds them. Viruses can lead to infections, which provoke an immune 
response that usually eliminates the infecting virus (Saddi et al. 2007; Loizzo et al. 2008).  
In 2007, Saddi and colleagues investigated the activities of the EOs from Artemisia 
arborescens L. (Asteraceae) against herpes simplex virus 1 and 2 (HSV-1 and HSV-2), 
since new prophylactic and therapeutic tools are needed. Using MTT assay, the result of 
this study showed that the IC50 values were 2.4 and 4.1 µg/mL for HSV-1 and HSV-2, 
respectively. Furthermore, the study showed that the antiviral activity of the EOs was 
principally due to direct virucidal effects, but also led to inhibition of the cell-to-cell virus 
diffusion of both HSV-1 and HSV-2 (Saddi et al. 2007). 
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An in vitro evaluation of the biological activity against HSV-1 was carried out with Cedrus 
libani A. Rich EO and ethanol extracts of cones, by Loizzo and collaborators (Loizzo et al. 
2008). In this study, it was shown that ethanol extracts and EO possess anti-viral activity 
with IC50 values of 0.50 mg/mL and 0.44 mg/mL, respectively. 
 
1.2.4 Antioxidant Activity 
Antioxidant compounds in food play an important role as a health-protecting factor (Saeed 
et al. 2012). Antioxidants reduce the risk for chronic diseases including cancer and heart 
diseases (Camire et al. 2005; Saeed et al. 2012).  
Primary sources of naturally occurring antioxidants are whole grains, fruits and vegetables 
(Saeed et al. 2012). Plant sources of food antioxidants like vitamin C, vitamin E, 
carotenes, phenolic acids, phytate and phytoestrogens have been recognized as having 
the potential to reduce disease risk (Camire et al. 2005; Saeed et al. 2012). Most of the 
antioxidant compounds in a typical diet are derived from plant sources and belong to 
various classes of compounds with a wide variety of physical and chemical properties. 
Some compounds, such as gallates, have strong antioxidant activity, while others, such as 
the monophenols are weak antioxidants (Camire et al. 2005; Saeed et al. 2012). 
The main characteristic of an antioxidant is its ability to trap free radicals. Highly reactive 
free radicals and oxygen species are present in biological systems from a wide variety of 
sources. These free radicals may oxidize nucleic acids, proteins, lipids or DNA and can 
initiate degenerative diseases (Saeed et al. 2012). Antioxidant compounds like phenolic 
acids, polyphenols and flavonoids scavenge free radicals such as peroxides, 
hydroperoxides or lipid peroxyl, and thus inhibit the oxidative mechanisms that lead to 
degenerative diseases (Saeed et al. 2012).  
In 2007, Sharififar and colleagues investigated the antioxidant and free radical scavenging 
activities of the EOs from flowers of Otostegia persica Boiss (Lamiaceae) (Sharififar et al. 
2007). This study showed that this EO possesses high antioxidant and radical scavenging 
activity in both DPPH (2,2-diphenyl-1-1-picrylhydrazyl) free radical scavenging test and 
ammonium thiocyanate tests. In the DPPH free-radical scavenging protocol, the EO 
showed antioxidant activity with an IC50 value of 19.8 µg/mL. In the second protocol, the 
EO exhibited an inhibition rate of oxidation of linoleic acid of 93.5% (percentage of total 
inhibition of oxidation) (Sharififar et al. 2007) 
1. Introduction 
41 
 
Chaieb and colleagues investigated the antioxidant properties of the EO in clove (Eugenia 
caryophyllata (L. Myrtaceae) (Chaieb et al. 2007). The antioxidant activity was evaluated 
by the DPPH free-radical scavenging test and the IC50 value was 0.2 µg/mL, revealing that 
the oil has a very strong radical scavenging activity (Chaieb et al. 2007). 
 
1.2.5 Anticancer Activity 
Despite recent advances in treatment modalities, cancer remains a major source of 
morbidity and mortality throughout the world (Edwards et al. 2005; Hesketh 2013). In the 
United States, cancer is the leading cause of death for individuals less than 85 years of 
age (Jemal et al. 2006). Moreover, the incidence of many cancers, including cancers of 
the skin, prostate, breast, and kidney, continues to increase (Edwards et al. 2005). A 
recent study, led by Cancer Research UK (CRUK), indicated that one in two individuals 
born after 1960 will be diagnosed with cancer at some point in their lifetime (Ahmad et al. 
2015) 
Cancer is, in fact, a general term that refers to over 100 distinct diseases affecting many 
different tissues and cell types. However, all forms of cancer are characterised by 
abnormal cell growth resulting from a relatively small number of inherited or 
environmentally-induced genetic mutations (Hesketh 2013). 
In their seminal review, Hanahan and Weinberg have argued that in order for a cell to 
become cancerous, it must acquire six unique traits as a result of altered cell physiology 
(Hanahan & Weinberg 2011). These defining traits of cancer cells are: (1) the ability to 
generate their own growth signals or respond to weak growth signals that are ignored by 
healthy cells; (2) insensitivity to anti-proliferative signals; (3) resistance to cell death by 
apoptosis; (4) the capacity for limitless replication; (5) the ability to stimulate new blood 
vessel development in order to allow for tumour growth; and (6) the capacity to invade 
tissues, at first locally, and later to spread or metastasize throughout the body (Hanahan & 
Weinberg 2011).. Although localized cancers can often be successfully treated by surgery 
and/or radiation therapy, chemotherapy remains the usual treatment of choice for 
advanced or metastatic disease (Espinosa et al. 2003). However, the use of conventional 
chemotherapeutic agents that typically target rapidly dividing cancer cells is often 
associated with deleterious side effects caused by inadvertent drug-induced damage to 
healthy cells and tissues (Cassidy et al. 2002). 
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Moreover, cancer cells that are quiescent or slowly proliferating are refractory to the 
cytotoxic effect of chemotherapeutic drugs that act at the level of DNA synthesis (Naumov 
et al. 2003). Cancer cells also frequently become resistant to chemotherapy as a 
consequence of cellular changes that include increased expression of drug-detoxifying 
enzymes and drug transporters, altered interactions between the drug and its target, 
altered DNA damage capacity, and defects in the cellular machinery that mediate 
apoptosis (Gatti & Zunino 2005). 
Therefore, the development of a new class of anticancer drugs that lack the toxicity of 
conventional chemotherapeutic agents and are unaffected by common mechanisms of 
chemoresistance would be a major advance in cancer treatment (Gatti & Zunino 2005).  
Some data strongly support the view that EOs have potential therapeutic applications in 
the prevention of cancer, but EOs remain mainly poorly researched. 
Ravizza and colleagues investigated the anticancer properties of linalool, a plant-
derivated monoterpene alcohol that is found in the essential oils from many aromatic 
plants (Ravizza et al. 2008). The cancer modules for this study were two human breast 
adenocarcinoma cell lines, MCF7 WT (wild type) and multi-drug resistant MCF7 AdrR 
(selected as being resistant to treatment with the chemotherapy agent Adriamycin, also 
known as doxorubicin). Linalool was used either as single agent or in combination with 
doxorubicin. Linalool treatment alone only mildly inhibited cell proliferation. However, at 
sub-toxic concentrations when in combination with doxorubicin, it led to increased 
doxorubicin-induced cytotoxicity and pro-apoptotic effects in both cell lines. It was 
therefore concluded that combination with linalool could lead to an improved therapeutic 
index of anthracyclines (such as doxorubicin) in the treatment of breast cancer, especially 
in multi-drug resistant tumours (Ravizza et al. 2008). 
Another study analysed the induction of mitochondria-associated (or intrinsic) apoptosis 
by EO extracted from Tanacetum gracile Hook., (Asteraceae), an alpine aromatic herb 
that contains about 40 components (Verma et al. 2008). This EO led to an inhibition the 
proliferation of the HL-60 leukaemia cell line, with an IC50 value of 27 µg/mL, associated 
with induction of apoptosis. Furthermore, the study showed that this effect was mediated 
by the mitochondria, since it led to a decrease of mitochondrial membrane potential, 
release of cytochrome C, activation of caspases-9 and -3, and an increase poly(ADP-
ribose)-polymerase (PARP) cleavage.  
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In another report, Medina-Holguín and colleagues reported on the chemo-typical variation 
of EOs in medicinal plant Anemopsis californica (Nutt.) Hook., Saururaceae (Medina-
Holguín et al. 2009). The authors extracted EOs from roots/rhizomes of the Anemopsis 
californica (ACEO) plant by steam distillation. It was then analysed for its effect on AN3CA 
(uterine) and HeLa (cervical) human cancer cell lines. The study showed an 
antiproliferative activity of the EO against both cell lines in vitro, with IC50 values of 
0.056% and 0.052% (v/v) for AN3CA and HeLa cells, respectively. The three main 
compounds, thymol, piperitone and methyleugenol, were tested independently for growth 
inhibition against the AN3CA and HeLa cells and also inhibited cell growth.  The IC50 
values for these three compounds against each cell line was determined and compared 
with the concentration of these compounds in the root oil of A. californica (Medina-Holguín 
et al. 2009). The inhibition may be the result of a synergistic relationship between the 
combined abundant compounds piperitone and methyleugenol, or also with a minor 
component in the oil. In conclusion, the study showed the specific bioactivity against 
uterine and cervical cancer cell lines of steam-distilled oil of Anemopsis californica root 
tissue, thus supporting the traditional and cultural use of ACEO to treat uterine cancer. 
Finally, another study analysed the antibacterial, antifungal, and anticancer activities of 
volatile oils and extracts from stems, leaves and flowers of Eucalyptus siderxylon A. Cunn 
and Eucalyptus torquata grown in Egypt (Ashour 2008). To analyse the anticancer activity, 
the sulforhodamine B (SRB) assay was used, an evaluation of cell density based on the 
measurement of cellular protein content (Ashour 2008). The in vitro cytotoxic activities of 
the essential oils and extracts were evaluated using the hepatocellular carcinoma cell line 
HEPG2 and the breast adenocarcinoma cell line MCF7. The results indicated that the 
EOs extracted from E. torquata leaves and stems and of E. sideroxylon leaves exert 
cytotoxic effect activity against MCF7 cells, but no effect on HEPG2 cells (Ashour 2008). 
 
1.3 Key concepts in cancer biology 
An abnormal cell that grows (increases in mass) and proliferates (divides) out of control 
will give rise to a tumour, or neoplasm (Knowles & Selby 2005). As long as the neoplastic 
cells have not yet become invasive, however, the tumour is said to be benign. For most 
types of such neoplasms, removing or destroying the mass locally usually achieves a 
complete cure. A tumour is considered a true cancer if it is malignant; that is, when its 
cells have acquired the ability to invade the surrounding tissue, and invasiveness is an 
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essential characteristic of cancer cells. It allows them to loose, intravase (or enter) into 
blood or lymphatic vessels, and form secondary tumours called metastases at distant 
sites in the body (Figure 1.3.1) (Knowles & Selby 2005). Key to early tumourgenesis is a 
deregulation of cell cycle progression and defective responses to DNA damage (Bartkova 
et al. 2005; Gorgoulis et al. 2005). 
Figure 1.3.1 - Benign versus malignant tumours. A benign glandular tumour (pink cells; an 
adenoma) remains inside the basal lamina (yellow) that marks the boundary of the normal structure 
(a duct, in this example). In contrast, a malignant glandular tumour (red cells; an adenocarcinoma) 
can develop from a benign tumour cell, and it destroys the integrity of the tissue, as shown (from 
Alberts et al. 2008). 
 
1.3.1 Cell cycle regulation 
The normal cell-cycle checkpoints governs cell-cycle progression at three major regulatory 
transitions (Karp 2002; Knowles & Selby 2005). The first is Start (or the restriction point) in 
late G1, where the cell commits to cell-cycle entry and chromosome duplication (Knowles 
& Selby 2005). The second is the G2/M transition, where the control system triggers the 
early mitotic events that lead to chromosome alignment on the mitotic spindle in 
metaphase. The third is the metaphase-to-anaphase transition, where the control system 
stimulates sister-chromatid separation, leading to the completion of mitosis and 
cytokinesis (Knowles & Selby 2005). The control system blocks progression through each 
of these transitions if it detects problems inside or outside the cell. If the control system 
senses problems in the completion of DNA replication, for example, it will hold the cell at 
the G2/M transition until those problems are solved (Karp 2002; Knowles & Selby 2005). 
Similarly, if extracellular conditions are not appropriate for cell proliferation, the control 
system blocks progression through Start, thereby preventing cell division until conditions 
become favourable (Karp 2002; Knowles & Selby 2005). 
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Central components of the cell-cycle control system are members of a family of protein 
kinases known as cyclin-dependent kinases (CDKs) (Karp 2002). The expression and 
activity of these kinases rise and fall as the cell progresses through the cycle, leading to 
cyclical changes in the phosphorylation of intracellular proteins that initiate or regulate the 
major events of the cell cycle (Karp 2002). An increase in CDK activity at the G2/M 
transition, for example, increases the phosphorylation of proteins that control chromosome 
condensation, nuclear-envelope breakdown, spindle assembly, and other events that 
occur in early mitosis (Karp 2002). 
Cyclical changes in CDK activity are controlled by a complex array of enzymes and other 
proteins (Knowles & Selby 2005). The most important of these CDK regulators are 
proteins known as cyclins. Cdks, as their name implies, are dependent on cyclins for their 
activity: unless they are bound tightly to a cyclin, they have no protein kinase activity. 
Cyclins were originally named because they undergo a cycle of synthesis and degradation 
in each cell cycle (Knowles & Selby 2005; Karp 2002). Cyclical changes in cyclin protein 
levels result in the cyclic assembly and activation of cyclin–CDK complexes at specific 
stages of the cell cycle (Karp 2002). 
 
Figure 1.3.1.1 - Cyclin–CDK complexes of the cell-cycle control system. The concentrations of the 
three major cyclin types oscillate during the cell cycle, while the concentrations of CDKs (not 
shown) do not change and exceed cyclin amounts. In late G1, rising G1/S-cyclin levels lead to the 
formation of G1/S-Cdk complexes that trigger progression through the Start transition. S-Cdk 
complexes form at the start of S phase and trigger DNA replication, as well as some early mitotic 
events. M-Cdk complexes form during G2 but are held in an inactive state; they are activated at the 
end of G2 and trigger entry into mitosis at the G2/M transition. A separate regulatory protein 
complex, the APC/C, initiates the metaphase- to- anaphase transition (from Alberts et al. 2008). 
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There are four classes of cyclins, each defined by the stage of the cell cycle at which they 
bind CDKs and function. All eukaryotic cells require three of these classes (Karp 2002) 
(Figure 1.3.1.1): 
1. G1/S-cyclins activate Cdks in late G1 and thereby help trigger progression through 
Start, resulting in a commitment to cell-cycle entry. Their levels fall in S phase. 
2. S-cyclins bind Cdks soon after progression through Start and help stimulate 
chromosome duplication. S-cyclin levels remain elevated until mitosis, and these cyclins 
also contribute to the control of some early mitotic events. 
3. M-cyclins activate Cdks that stimulate entry into mitosis at the G2/M transition.M-cyclin 
levels fall in mid-mitosis. 
4. The G1-cyclins helps govern the activities of the G1/S-cyclins, which control 
progression through Start in late G1. 
 
1.3.2 The DNA damage response  
Progression through the cell cycle, and thus the rate of cell proliferation, is controlled not 
only by extracellular mitogens but also by other extracellular and intracellular signals 
(Morgan 2007). A key factor for induction of cell cycle arrest is the presence of DNA 
damage, which can occur as a result of spontaneous chemical reactions in DNA, errors in 
DNA replication, or exposure to radiation or exogenous chemicals (Morgan 2007). It is 
essential that damaged DNA and chromosomal damage are repaired before attempting to 
duplicate or segregate them (Morgan 2007; Bertoli et al. 2013). The cell-cycle control 
system can readily detect DNA damage and arrest the cycle at three DNA damage 
checkpoints transitions: at the transition of G1 and S (G1/S), which prevents entry into the 
cell cycle and into S phase; during S-phase, when DNA replication stalling can be 
detected (intra-S); and at the G2/M transition (G2/M), which prevents entry into mitosis 
(Morgan 2007; Bertoli et al. 2013). 
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Figure 1.3.2.1 - How DNA damage arrests the cell cycle in G1 phase. When DNA is damaged, 
various protein kinases are recruited to the site of damage and initiate a signalling pathway that 
causes cell-cycle arrest. The first kinase at the damage site is either ATM or ATR, depending on 
the type of damage. Additional protein kinases, called Chk1 and Chk2, are then recruited and 
activated, resulting in the phosphorylation of the transcription regulatory protein p53. Mdm2 
normally binds to p53 and promotes its ubiquitylation and destruction in proteasomes. 
Phosphorylation of p53 blocks its binding to Mdm2; as a result, p53 accumulates to high levels and 
stimulates transcription of numerous genes, including the gene that encodes the CKI protein p21. 
The p21 binds and inactivates G1/S-Cdk and S-Cdk complexes, arresting the cell in G1. In some 
cases, DNA damage also induces either the phosphorylation of Mdm2 or a decrease in Mdm2 
production, which causes a further increase in p53 (not shown) (from Alberts et al. 2008). 
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DNA damage is detected by a series of protein complexes, which are recruited to the site 
of damage and activate the apical protein kinases ATM (Ataxia Telangiectasia mutated) 
and ATR (ATM and rad3 related). The DNA damage response (DDR) signalling continues 
via the ATM/ATR-mediated phosphorylation of various target proteins, including two other 
protein kinases, Chk1 (checkpoint kinase 1) and Chk2 (checkpoint kinase 2) (Karp 2002; 
Knowles & Selby 2005). These kinases phosphorylate further target proteins leading to 
various response pathways, including cell-cycle arrest, apoptosis and DNA repair. A key 
DDR target in both cell cycle arrest regulation and apoptosis is the transcription factor 
p53, which stimulates transcription of the gene encoding p21, a CKI (cyclin-dependent 
kinase inhibitor) protein. p21 binds to G1/S phase-CDK/Cyclin and S phase-CDK/cyclin 
complexes and inhibits their activity, thereby inhibiting the entry into the next stage of the 
cell cycle (figure 1.3.2.1) (Knowles & Selby 2005). 
DNA damage activates p53 by an indirect mechanism. In undamaged cells, p53 
concentration is kept at very low level via proteasomal degradation mediated by the E3 
ligase MDM2 (Mouse double minute 2 homolog) (Knowles & Selby 2005). 
Phosphorylation of p53 by ATM, ATR, Chk1 and Chk2 after DNA damage reduces its 
affinity to MDM2, leading to a decrease in p53 degradation and a marked increase in p53 
concentration in the cell, also know as p53 stabilisation. In addition, the decreased binding 
to MDM2 enhances the ability of p53 to stimulate gene transcription (Knowles & Selby 
2005). 
The protein kinases Chk1 and Chk2 also block cell-cycle progression by phosphorylating 
members of the CDC25 (cell division cycle 25) family of protein phosphatases, thereby 
inhibiting their function. These phosphatases are particularly important in the activation of 
mitotic CDKs at the beginning of mitosis. Chk1 and Chk2 phosphorylate CDC25 at 
inhibitory sites that are distinct from the phosphorylation sites that stimulate CDC25 
activity. The inhibition of CDC25 activity by DNA damage helps block entry into mitosis 
(Knowles & Selby 2005). 
 
1.3.3 Study of cell cycle progression 
One simple method to determine where in the cell cycle a specific cell is, is it to observe 
living cells with a microscope (Knowles & Selby 2005). A glance at a population of 
mammalian cells proliferating in culture reveals that a fraction of the cells have rounded 
up and are in mitosis. Others can be observed in the process of cytokinesis (Knowles & 
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Selby 2005). Is possible to gain additional information about the position on the cell cycle 
by staining the cells with DNA-binding fluorescent dyes (which reveal the condensation of 
chromosomes in mitosis) or with antibodies that recognize specific cell components such 
as the microtubules (revealing the mitotic spindle), or other mitotic markers. Cells in S 
phase can be identified in the microscope by labelling with molecules that are 
incorporated into newly synthesized DNA, such as the thymidine halogenated analogue 
BrDU (BromoDeoxyUridine) and can be detected by immunofluorescence (Knowles & 
Selby 2005). 
Another widely used methodology to assess the stage that a cell has reached in the cell 
cycle is by measuring the DNA content, which doubles during S phase (Knowles & Selby 
2005). This approach is greatly facilitated by the use of fluorescent DNA-binding dyes and 
a flow cytometer, which allows the rapid and automatic analysis of large numbers of cells 
(figure 1.3.3.1). Using flow cytometry allows to determine the lengths of G1, S and G2+M 
phases, by measuring the DNA content in asynchronous cell populations (Knowles & 
Selby 2005). 
Figure 1.3.3.1 - Analysis of DNA content with a flow cytometer. This graph shows typical results 
obtained for a proliferating cell population when the DNA content of its individual cells is 
determined in a flow cytometer. A flow cytometer, also called a fluorescence-activated cell sorter, 
or FACS, can also be used to sort cells according to their fluorescence. The cells analysed here 
were stained with a dye that becomes fluorescent when it binds to DNA, so that the amount of 
fluorescence is directly proportional to the amount of DNA in each cell. The cells fall into three 
categories: those that have an unreplicated complement of DNA and are therefore in G1, those that 
have a fully replicated complement of DNA (twice the G1 DNA content) and are in G2 or M phase, 
and those that have an intermediate amount of DNA and are in S phase. The distribution of cells 
indicates that there are greater numbers of cells in G1 than in G2 + M phase, showing that G1 is 
longer than G2 + M in this population (from Alberts et al. 2008). 
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1.4 Dune Plant Species selected in this study 
Vegetation patterns in coastal sand dunes hold particular interest for ecologists, in part 
because of their clear interaction with the dune geomorphology (Cowles 1911). Coastal 
sand dunes are subjected to severe environmental stresses and disturbance, caused by 
salinity, drought, nutrient limitation, substrate instability, sand burial, wind abrasion, 
erosion of the coastline and storms (Gornish & Miller 2010).  
Sand-dune species, due to their understudied and unexplored stress adaptation 
mechanisms and strategies present an opportunity for the discovery of new bioactive 
molecules (Murray et al. 2013). However, although work in this field has expanded in the 
last few years, the role of EOs as potential anti-cancer agents is still not fully explored 
(Gautam et al. 2014; Bhalla et al. 2013). 
The aromatic plants present in the sand dunes of Peniche, Portugal chosen for this 
research are described below: 
 
 
1.4.1 Crithmum maritimum L. 
This species, commonly known as sea fennel or rock samphire, is a perennial member of 
the Apiaceae family (Meot-Duros et al. 2010). This halophytic plant grows in sand hills and 
is often found on rocky cliffs (figure 1.4.1.1). It has been attributed many interests in 
traditional medicine, including diuretic, antiscorbutic, digestive and purgative properties, 
and can be consumed as a condiment (Atia et al. 2006).  
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Figure 1.4.1.1 – Crithmum maritimum. A) Photography of Crithmum maritimum in Peniche and B) 
geographic distribution map of this species in Portugal (extracted from Flora-On: Flora de Portugal 
Interactiva, Sociedade Portuguesa de Botânica, http://www.flora-on.pt/#/1crithmum+maritimum). 
 
 
1.4.2 Seseli tortuosum L. 
This species belongs to the family Apiaceae, which is composed of aromatic herbs and 
economically important species that are used as foods, spices, condiments and 
ornamentals (Lawrence 1995; Crowden et al. 1969; Pimenov & Leonov 1993). It is 
possible to find this species in psammophilous bushes in the secondary dune, less 
frequent in maritime rocks and slopes of saline (Pimenov & Leonov 1993). Several Seseli 
species are reported in ancient literature for various healing effects, namely herbal 
remedy for human inflammation, swelling, rheumatism, pain and common cold (Hu et al. 
1990). In Turkish folk medicine, the fruit of Seseli tortuosum (figure 1.4.2.1) is used as 
emmenagogue and antiflatulent (Baytop 1999). This EO have been investigated for its 
various biological properties including anti-inflammatory, antinociceptive (Küpeli et al. 
2006; Tosun et al. 2006) and antifungal activities (Gonçalves et al. 2012).  
 
 
 
A) B) 
1. Introduction 
52 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4.2.1 – Seseli tortuosum. A) Photography of Seseli tortuosum in Consolação beach, 
Peniche and B) geographic distribution map of this species in Portugal (extracted from Flora-On: 
Flora de Portugal Interactiva, Sociedade Portuguesa de Botânica, http:// www.flora-
on.pt/#wSeseli+tortuosum). 
 
 
1.4.3 Artemisia campestris subsp. maritima (DC.) Arcang. 
The genus Artemisia L. is widespread throughout the world, growing wild over the 
Northern Hemisphere and belongs to the Asteraceae family. Artemisia campestris subsp. 
maritima (Figure 1.7.3.1) grows in Coastal sands, usually in primary dunes (figure 1.4.3.1) 
(Djeridane et al. 2007). This species has been used as febrifuge, vermifuge, against 
digestive troubles, gastric ulcer, menstrual pain (Dob et al. 2005; Djeridane et al. 2007) 
and for medicinal uses, such as antispasmodic and antihelmintic (Naili et al. 2010). 
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Figure 1.4.3.1 - Artemisia campestris subsp. maritima. A) Photography of Artemisia campestris 
subsp.  maritima in Consolação beach, Peniche and B) geographic distribution map of this species 
in Portugal (extracted from Flora-On: Flora de Portugal Interactiva, Sociedade Portuguesa de 
Botânica, http:// www.flora-on.pt/#wArtemisia+campestris). 
 
1.4.4 Juniperus turbinata Guss. subsp. turbinata 
The genus Juniperus L. (Cupressaceae) is represented approximately by 70 species in 
the Northern Hemisphere (Nakanishi et al. 2004; Seca & Silva 2005). Juniperus turbinata 
subsp. turbinata (figure 1.4.4.1) is a bush growing in relatively dry conditions in stabilized 
dunes and coastal cliffs, but also on rocky slopes thermophilic, limestone outcrops and 
embedded river valleys (figure 1.4.4.1) (Seca & Silva 2005). Studies regarding the 
proprieties of Juniperus species occurring in Portugal have been even more limited and 
the focus again was on its EOs (Cavaleiro et al. 2001; Cavaleiro et al. 2002; Cavaleiro et 
al. 2003). Plants of the genus Juniperus are used in different European cuisines as spice 
and flavouring alcoholic drinks, as well as in cosmetics (Loizzo et al. 2008). These plants 
have an extensively history of use in global folk medicine for various disorders, such as 
common colds, urinary and kidney infections and dermatological disorders (Allen & 
Hatfield, 2004). Many biological activities have been reported for Juniperus sp. These 
include anti-inflammatory (Akkol et al. 2009; Lesjak et al. 2011), diuretic, antiseptic 
(bacterial and fungal) (Cavaleiro et al. 2006; Ennajar et al. 2009), anthelmintic (Kozan et 
al. 2006), hypoglycaemic (Ju et al. 2008), hypotensive, abortifacient, antinociceptive 
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(Akkol et al. 2009), antiviral (Sassi et al. 2008), anticancer (Kusari et al. 2011), anti-
oxidant (Lesjak et al. 2011) and analgesic properties (Lesjak et al. 2011).  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4.4.1 – Juniperus turbinata subsp. turbinata. A) Photography of Juniperus turbinata in 
Consolação beach, Peniche and B) geographic distribution map of this species in Portugal 
(extracted from Flora-On: Flora de Portugal Interactiva, Sociedade Portuguesa de Botânica, http:// 
www.flora-on.pt/#wJuniperus+turbinata). 
 
1.4.5 Otanthus maritimus (L.) Hoffmans. & Link 
This species belongs to the family Asteraceae and it is a strongly aromatic perennial herb, 
15–30 cm tall, growing on maritime sands along the coasts of South and West Europe, 
northwards to South-East Ireland (figure 1.4.5.1). The plant has been employed in folk 
medicine in decoctions as tonics, dyspeptics and for the treatment of toothache, asthmatic 
bronchitis, dysentery and inflammation of the urinary bladder. Dry specimens have been 
traditionally used as decoration and as insect repellent (Reutter 1923; Tsoukatou et al. 
2000). 
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Figure 1.4.5.1 – Otanthus maritimus. A) Photography of Otanthus maritimus in Consolação beach, 
Peniche and B) geographic distribution map of this species in Portugal (extracted from Flora-On: 
Flora de Portugal Interactiva, Sociedade Portuguesa de Botânica, http:// www.flora-
on.pt/#wOtanthus+maritimus). 
 
1.4.6 Eryngium maritimum L. 
The genus Eryngium L. belongs to the family Apiaceae and includes around 250 species 
that are widespread throughout the world (Darriet et al. 2014). Among them, several 
Eryngium species have been used as ornamental plants, condiments or in traditional 
medicine (Küpeli et al. 2006; Darriet et al. 2014). Eryngium maritimum, usually named 
‘sea holly’ in England or ‘Panicaut desmers’ in France, is a perennial plant (30–60 cm 
high) with mauve flowers (blossoming time, June–September), growing wild on the sandy 
beaches of western Europe, the Mediterranean basin and the Black Sea (figure 1.4.6.1) 
(Küpeli et al. 2006; Darriet et al. 2014). The plant is one of the typical dune species 
implicated in the plant network that contributes to sand dune edification and restoration 
(Darriet et al. 2014). Eryngium maritimum has also been reported to exhibit different 
therapeutic uses in folk medicine (Küpeli et al. 2006). 
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Figure 1.4.6.1 – Eryngium maritimum. A) Photography of Eryngium maritimum in Consolação 
beach, Peniche and B) geographic distribution map of this species in Portugal (extracted from 
Flora-On: Flora de Portugal Interactiva, Sociedade Portuguesa de Botânica, http:// www.flora-
on.pt/#wEryngium+maritimum). 
 
1.5 Aim of this study 
Essential oils have been widely used for medicinal purposes, due to their variety of 
biological properties such as antibacterial, antiviral, antioxidant, antiparasitical and anti-
inflammatory properties. Their potential anticancer properties have not yet been properly 
clarified.  
This study has the objective to determine the efficacy of the essential oils from six 
selected taxa from the sand dunes of Peniche (Portugal): Artemisia campestris subsp. 
maritima, Crithmum maritimum, Eryngium maritimum, Juniperus turbinata subsp. 
turbinata, Otanthus maritimus and Seseli tortuosum as potential cytotoxic/cytostatic 
therapeutic agents in breast (MCF7) and colorectal (RKO) cancer cell lines. 
In a first stage, for every EOs enumerated, the cellular viability will be evaluated, in both 
cell lines, by MTS assay using serial dilutions with starting concentrations of 5 µL/mL and 
1 µL/mL. From these results, the concentration of the EOs required for 50% inhibition in 
vitro (IC50) will be calculated for each species, in both cancer cell lines. 
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The two EOs that present the lowest IC50, representing the EOs that could have a 
decrease in cell viability more pronounced, will be selected and will be part of a 
preliminary study of mode of action the EOs. Western blot will be carried out in order to 
understand the effects of the EOs on cell death. According to the results obtained, we will 
proceed to the next stage, in order to study in more detail the mechanism of action of EOs 
in cancer cells. For this, the cell cycle progression will be studied, in order to understand 
the effect of the EOs in cell cycle arrest, using fluorescence-activated cell sorting (FACS) 
technique. 
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2.1 General materials and reagents 
All general reagents were purchased from Fisher Scientific (UK), Sigma-Aldrich (UK) or 
VWR (UK), unless stated. All tissue culture reagents were purchased from PAA (UK), 
Gibco (UK) or Lonza (US). 
 
2.2 Plant Material  
Aerial parts of Artemisia campestris subsp. maritima, Crithmum maritimum, Eryngium 
maritimum, Juniperus turbinata subsp. turbinata, Otanthus maritimus and Seseli 
tortuosum were collected during the flowering stage in July 2013, in the sand dunes of 
Consolação beach, Peniche (Portugal).  
Voucher specimens were deposited in the Herbarium of Medicinal Plants, Faculty of 
Pharmacy, University of Coimbra, under the numbers: J. Poças 02013 (Artemisia 
campestris subsp. maritima), J. Poças 06013 (Crithmum maritimum), J. Poças 02013 
(Eryngium maritimum), J. Poças 05013 (Juniperus turbinata subsp. turbinata), J. Poças 
01013 (Otanthus maritimus) and J. Poças 04013 (Seseli tortuosum). 
 
2.3 Essential oils isolation 
Essential oils were isolated by hydrodistillation for 3h using a Clevenger-type apparatus, 
according to the procedure described in the European Pharmacopoeia (Council of Europe 
1997) and stored in appropriate vials at 4ºC.  
 
2.4 Chemical characterization of essential oils 
2.4.1 Gas chromatography (GC) 
      
Analytical GC was carried out in a Hewlett-Packard 6890 (Agilent Technologies, Palo Alto, 
CA, USA) chromatograph with a HP GC ChemStation Rev. A.05.04 data handling system, 
equipped with a single injector and two flame ionization detectors (FID). A graphpak 
divider (Agilent Technologies, part no. 5021-7148) was used for simultaneous sampling to 
two Supelco (Supelco, Bellefonte, PA, USA) fused silica capillary columns with different 
stationary phases: SPB-1 (polydimethylsiloxane 30 m × 0.20 mm, film thickness 0.20 µm), 
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and SupelcoWax-10 (polyethyleneglycol 30 m × 0.20 mm, film thickness 0.20 µm). Oven 
temperature program: 70–220ºC (3ºC/min), 220 ºC (15 min); injector temperature: 250ºC; 
carrier gas: helium, adjusted to a linear velocity of 30 cms−1; splitting ratio 1:40; detectors 
temperature: 250ºC. 
 
2.4.2 Gas chromatography-mass spectrometry (GC-MS) 
GC–MS was carried out in a Hewlett-Packard 6890 gas chromatograph fitted with a HP1 
fused silica column (polydimethylsiloxane 30 m × 0.25 mm, film thickness 0.25 µm), 
interfaced with an Hewlett-Packard mass selective detector 5973 (Agilent Technologies) 
operated by HP Enhanced ChemStation software, version A.03.00. GC parameters as 
described above; interface temperature: 250ºC; MS source temperature: 230ºC; MS 
quadrupole temperature: 150 ◦C; ionization energy: 70 eV; ionization current: 60µA; scan 
range: 35–350 units; scans per second: 4.51. 
 
2.4.3 Qualitative and quantitative analyses 
Components of the volatile oil were identified by their retention indices on both SPB-1 and 
SupelcoWax-10 columns, calculated by linear interpolation relative to retention times of 
C8–C24 of n-alkanes and compared with those of reference compounds included in CEF 
laboratory database or literature data (Adams 2004), and by their mass spectra by 
matching with reference spectra from the CEF laboratory own spectral database, 
Wiley/NIST database or literature data (Joulain & Konig, 1998; Adams, 2004; Wiley 
Registry, 2006). Relative amounts of individual components were calculated based on GC 
raw data areas without FID response factor correction. 
 
2.5 Cell Culture 
Human cancer cell lines RKO (colorectal) and MCF7 (breast) (ATCC -US- or ECCAC -UK-
), were maintained in DMEM (Dulbecco’s Modified Eagle’s) medium supplemented with 
10% foetal bovine serum (FBS) and 1% sodium pyruvate. Cells were grown in a 37˚C 
incubator, at a 5% CO2 humidified atmosphere (90% humidity). The subculture was made 
three times a week in T75 flasks. Initially, the medium was removed from the flask and 
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cells were washed with 1x Phosphate Buffered Saline (PBS) without calcium or 
magnesium. The PBS was then removed and Trypsin was added for promoting cell 
detachment. After incubation for 2-5 mins at 37˚C, cells were resuspended in fresh media 
and subcultured at a ratio of 1:6 to 1:12. Cells were regularly tested for Mycoplasma 
infection absence. 
 
2.6 Treatment of cancer cells with EOs 
The serial dilution of the EO was prepared in DMSO. For stock solution were used a 
proportion 1:4 of EO per DMSO. The starting concentrations were prepared at 5 µL/mL 
(figure 2.6.1) and 1 µL/mL (figure 2.6.2), using dilutions ranges of 1:2 and 1:10, 
respectively. 
Figure 2.6.1 – Diagram relative to the preparation of dilutions of EOs. Initially, the working solution 
was prepared at a ratio 1:4 (EO per DMSO). 80 µL were pipetted for 4 mL of medium, thus making 
the final concentration 5 µL/mL. The serial dilutions (until 0, 16 µL/mL) was made in dilution 1:2. 
The last samples were prepared by 80 µL DMSO added with 4 mL of medium and just medium, 
respectively. Previously, RKO and MCF7 cell lines were seeded into 96 well microtiter plates, at a 
density of 1x104 and 5x103 cells per well, respectively. For each EO and cancer cell line was made 
two intra replicas. 
Figure 2.6.2 – Diagram relative to the preparation of dilutions of EOs. Initially, the working solution 
was prepared at a ratio 1:4 (EO per DMSO). 16 µL were pipetted for 4 mL of medium, thus making 
the final concentration 1 µL/mL. The serial dilutions (until 10-5 µL/mL) was made in dilution 1:10. 
The last samples were prepared by 16 µL DMSO added with 4 mL of medium and just medium, 
respectively. Previously, RKO and MCF7 cell lines were seeded into 96 well microtiter plates, at a 
density of 1x104 and 5x103 cells per well, respectively. For each EO and cancer cell line was made 
two intra replicas. 
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2.7 MTS (3-(4,5-dimethylthazol-2-yl)-2,5-diphenyl tetrazolium bromide) Assay 
for cellular viability 
The assay is dependent on the reduction of the tetrazolium salt MTS (3-(4,5-
dimethylthazol-2-yl)-2,5-diphenyl tetrazolium bromide) by the mitochondrial 
dehydrogenase of viable cells to form a blue formazan product (Figure 2.6.1). This 
conversion is presumably accomplished by NADPH or NADH produced by these 
dehydrogenase enzymes (Berridge & Tan 1993). The assay measures cell respiration and 
the amount of formazan produced is proportional to the number of living cells present in 
culture (Mosmann 1983; Gerlier & Thomasset 1986).  It is a sensitive, quantitative and 
reliable colorimetric assay that measure viability, proliferation and activation of cells 
(Vega-Avila & Pugsley 2011). Due to toxicity associated with exposure to MTS assay, is 
impossible to conduct follow-up cell culture assessments. 
MTS assay (CellTiter 96® AQueous (Promega)) was performed according to manufacturer’s 
instructions. In brief, the spent medium of each well was removed and fresh medium was 
added as well as MTS reagent solution. After 4 hours incubation, the absorbance was 
determined using a microplate reader (Bioteck ELx800, UK) at a test wavelength of 490 
nm. 
Figure 2.7.1 – Structures of MTS tetrazolium and its formazan product (CellTiter 96® AQueous One 
Solution Cell Proliferation Assay). 
 
2.8 Half maximal inhibitory concentration (IC50) calculations 
A dose-response curve describes the relationship between response to drug treatment 
and drug dose or concentration. The IC50 measures how effective a drug is. It indicates 
how much of a particular drug treatment is needed to inhibit a given biological process 
(i.e. an enzyme, cell or microorganism, etc.) by half (50 %).  
2. Materials and Methods 
63 
 
According to the Food and Drug Administration (FDA), IC50 represents the concentration 
of a drug that is required for 50% inhibition in vitro.  To calculate the IC50 values, Graph 
Pad Prism Software (GraphPad Software, Inc.) was used. The tools used in this software 
were “Dose- Response Inhibition” and “Log (Inhibition) vs response (three responses)”. 
These tools were selected because it was necessary to create a curve that better 
describes the concentration tested versus inhibition of cellular viability by MTS assay, and 
also to normalize the concentrations in Log10, in order to calculate the correct IC50 values. 
 
2.9 Protein Lysis and Protein Concentration Determination 
After incubation, the medium on treated or untreated cell cultures was removed, and cells 
were washed in 1x PBS. Cells were harvested into PBS using a cell scrapper. The cells 
were collected in microcentrifuge tubes and pelleted by centrifugation at high speed for 10 
seconds and the supernatant was removed. The pellet was resuspended with UTB lysis 
buffer (9M Urea, 75mM Tris-HCl pH 7.5 and 0.15M β-mercaptoethanol). Lysates were 
then sonicated during 5 minutes. After, samples were centrifuged at 500g during 15 min 
(at 4°C) and the resulting supernatant was transferred to a falcon tube. Protein 
concentration was determined using on NanoDrop spectrophotometer software (ND-1000 
version 3.5.2). 
 
2.10 SDS-PAGE and Western Blot 
Samples were prepared for loading into an SDS-PAGE (Sodium Dodecyl Sulphate 
Polyacrylamide Gel Electrophoresis) gel at a final protein amount of 50 µg. 
Due to the molecular weight of the proteins used subsequently, 10% SDS-PAGE gels 
were prepared. For this, the running gel was prepared with 1.5 M Tris pH 8.8, Acrylamide, 
10% SDS, 10% APS and TEMED (Tetramethylethylenediamine), and stacking gel with 0.5 
M Tris pH 6.8, Acrylamide, 10% SDS, 10% APS and TEMED. For the running buffer 10x 
was needed Tris base, glycine and 10% SDS, for a final volume 1 L of water. SDS-PAGE 
gels were run in 1x running buffer at 120 volts over 90 minutes. 
The Blotting buffer 10x was prepared with Tris base and glycine, to a final volume of 1 L of 
water. The nitrocellulose membranes were cut and placed in 1x blotting buffer to 
equilibrate.  
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After electrophoresis, membranes were place, correctly, between 2 sponges and 2 set of 
pieces and blotting paper onto sponge. The gels were placed onto blotting paper (all 
bubbles removed) and membrane onto gel. After the membrane was covered with blotting 
paper, the set of pieces were closed with sponge between membrane and blotting paper, 
and placed in blotting tank half filled with blotting buffer. This way, blotting was prepared 
to run at 100 volts, during 90 minutes. After, the membranes were washed in Tris-Buffered 
Saline - 0.1% Tween (TBS-T) and blocked with 5% milk in TBS-T during 1 hour. 
The membranes were incubated with primary antibodies (prepared in 1% dried milk 
powder in TBS-T), overnight at 4°C, and after that washed again with TBS-T. Membranes 
were then incubated in secondary antibody solution (prepared in 1% milk in TBS-T) for 1 
hour at room temperature. After further washes with TBS-T, membranes were incubated 
before using Enhanced Chemiluminescence (ECL) reagent (Biorad) and developed using 
the Fluorescent Imager system (Biorad) using the Imager Lab software (Image Lab 
software, version 5.1). The antibodies used for Western Blot analysis are described in 
Table I. 
Table I – List of antibodies used for western blot technique. 
Antibody Branch/ catalogue number Dilution Animal Origin 
p53 Santa Cruz Biotechnology / sc-126 1:1000 Mouse 
p21 EMD Millipore / 05655 1:1000 Mouse 
Cleaved Caspase 3 Cell Signalling Technology / #9661 1:1000 Rabbit 
β-Actin Santa Cruz Biotechnology / sc-
130656 
1:10000 Mouse 
HRP-tagged Anti-mouse secondary 
antibody 
Dako / P 0260 1:2000 Rabbit 
HRP-tagged Anti-rabbit secondary 
antibody 
Dako / P 0448 1:2000 Goat 
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2.11 Determination of DNA content by Fluorescence-activated cell sorting 
(FACS) 
The nuclear DNA content of a cell can be quantitatively measured at high speed by flow 
cytometry. Initially, a fluorescent dye that binds stoichiometrically to the DNA is added to a 
suspension of permeabilised single cells or nuclei (Ormerod 1992). The principle is that 
the stained material has incorporated an amount of dye proportional to the amount of DNA 
(Ormerod 1992). The stained material is then measured in the flow cytometer and the 
emitted fluorescent signal yields an electronic pulse with a height (amplitude) proportional 
to the total fluorescence emission from the cell. Thereafter, such fluorescence data are 
considered a measurement of the cellular DNA content (Ormerod 1992). 
To measure the DNA content, cells need to be stained with a fluorescent dye that binds to 
DNA in a manner that reflects the amount of DNA present. The most widely used dye is a 
propidium iodide (PI), which has red fluorescence and can be excited at 488 nm.  
Cells were trypsinised and resuspended in order to obtain a single cell suspension 
(collected cold media from each dish to avoid the clumping of cells) and were centrifuged 
(at 500g, during 5 minutes). The cells were resuspended in ice cold PBS and centrifuged 
again. The pellet was resuspended in a small volume of ice cold PBS and ice cold 70% 
ethanol (EtOH) was added dropwise while vortexing. Fixed cells were stored at -20°C. 
For staining, samples centrifuged at 500g, during 5 minutes. After, they were resuspended 
for blocking in 2% BSA (Bovine Serum Albumin) (Cell Signalling Technology) in 0.1% 
tween/PBS and, and centrifuged. The cell pellet was resuspended in 10 µg/mL PI (Fisher 
Scientific) and 10 µg/mL RNAse A (Fisher Scientific) in PBS and were incubated on ice up 
to an hour and transferred to FACS tube. Samples were then analysed using a BD Cell 
QuestTM Pro FACS instrument. 
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3.1 Essential oils composition 
Through hidrodistillation technique, every EOs tested, were extracted. To maintain their 
properties, they were saved in appropriate vials and were protected by light and air. 
EOs chemical composition was studied though gas chromatography (GC) and gas 
chromatography-mass spectrophotometry (GC-MS) to understand which major 
compounds exist in each EO tested. 
For this, a small volume sample (1 µL) of each EO was injected into the GC/ GC-MS and 
analyzed individually. 
The yield and main compounds of the six species studied are listed in the table I.  
 
Table II - Species with respective yield and main compounds of the essential oils. 
Species Yield 
(%) 
Main compounds (above 10%, except Eryngium 
maritimum) 
Artemisia campestris 
subsp. maritima 
0.47 β-pinene, sesquiterpenes 
Crithmum maritimum 0.36 γ-terpinene, thymol methyl ether, sabinene 
Eryngium maritimum 0.08 germacrene D and other sesquiterpene hidrocarbons  
(all below 10%) 
Juniperus turbinata 
subsp. turbinata 
0.29 α-pinene, β-phellandrene, α-terpinyl acetate 
Otanthus maritimus 0.12 filifolone, chrysanthenone, cis-chrysantenyl acetate 
Seseli tortuosum 0.66 α-pinene, β-pinene, (Z)- β –ocimene 
 
 
3.2 Antitumor Activity  
To determine the antitumor activity of the EOs extracted from these species, MCF7 
(breast) and RKO (colorectal) cancer cells were treated with the various extracted EOs for 
3 days at two serial dilution ranges: 1:2 (starting at 5 µL/mL) and 1:10 (starting at 1 
µL/mL). After this, an MTS assay was carried out, and cell viability was calculated 
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comparing to the vehicle (DMSO), corresponding to 100% cellular viability. Each EO was 
initially diluted in DMSO (vehicle) and further diluted in growing medium.  
Cells were treated with serial dilutions of 1:2 starting at a concentration of 5 µL/mL (figure 
2.6.1).  
The results of the MTS assay for all EOs on the RKO cell line treated at a starting 
concentration of 5 µL/mL are shown in Figure 3.2.1. 
For MCF7 cell line, the results of MTS assay in the serial dilutions at a starting 
concentration of 5 µL/mL are shown in figure 3.2.2. 
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Figure 3.2.1 - Effect of EO treatment on RKO cells on cell viability (serial dilutions 1:2 starting at 5 
µL/mL concentration). Oils used in this study were extracted from the Peniche dune plants A) 
Crithmum maritimum (n=3), B) Seseli tortuosum (n=3), C) Artemisia campestris (n=2), D) Juniperus 
turbinata (n=4), E) Otanthus maritimus (n=4) and F) Eryngium maritimum (n=3). The starting 
concentration of each EO was 5 µL/mL, further serially diluted 1:2 up to 0.16 µL/ml. RKO cells were 
seeded in a 96 well plate at a density 1x104 cells per well and treated with the diluted oil solutions. 
After 72 hours of incubation, an MTS assay was performed for each plate, according to 
manufacturers instructions. Values represent the % of cellular viability as assessed by the MTS 
assay. 
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Figure 3.2.2 - Effect of EO treatment on MCF7 cells on cell viability (serial dilutions 1:2 starting at 5 
µL/mL concentration). Oils used in this study were extracted from the Peniche dune plants A) 
Crithmum maritimum (n=3), B) Seseli tortuosum (n=3), C) Artemisia campestris (n=2), D) Juniperus 
turbinata (n=4), E) Otanthus maritimus (n=4) and F) Eryngium maritimum (n=3). The starting 
concentration of each EO was 5 µL/mL, further serially diluted 1:2 up to 0.16 µl/ml. RKO cells were 
seeded in a 96 well plate at a density 5x103 cells per well and treated with the diluted oil solutions. 
After 72 hours of incubation, an MTS assay was performed for each plate, according to 
manufacturers instructions. Values represent the % of cellular viability as assessed by the MTS 
assay.  
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All the EOs exhibited anticancer activity against RKO cells, as shown by a clear de-
creased in cell viability as measured by the MTS assay. Artemisia campestris, Otanthus 
maritimus, Seseli tortuosum and Eryngium maritimum EOs, treatment with our lowest 
dose for this dilution range (0.16 μL/mL, the lowest concentration tested) led to a clear 
decrease in cellular viability. However, Seseli tortuosum and Eryngium maritimum EOs 
treatment had a less toxic effect on the cells as the other species of EOs, as can be ob-
served in the graphs. 
Against MCF7 cell line, every EOs exhibited a decrease in cellular viability as measured 
by the MTS assay. The effect of Seseli tortuosum EO on cellular viability was the less 
toxic of all the species, with other EOs inducing a clear decrease in cellular viability at the 
lowest dose used. Interestingly, Eryngium maritimum EO promoted an increase in cellular 
viability or proliferation at the same dose range. 
As the dilution range starting at 5 µL/mL concentration were shown to be very toxic to the 
cells for the majority of EOs (figures 3.2.1 and 3.2.2), it was decided to test a lower 
concentration range of EO dilutions, with a wider dilution ratio. The starting concentration 
chosen was 1 µL/mL with a dilution 1:10 series.  
MCF7 and RKO cells were treated with the various EOs already described for three days, 
after which MTS assay was carried out, and cell viability was calculated comparing to the 
vehicle (DMSO), corresponding to 100% cellular viability, as described before, except the 
staring concentration was 1 µL/mL, with a dilution ratio of 1:10 (figure 2.6.2). 
The results of the MTS assay for all EOs on the RKO cell line treated at a starting 
concentration of 1 µL/mL are shown in figure 3.2.3. 
For MCF7 cell line, the results of MTS assay in the serial dilutions at a starting 
concentration of 1 µL/mL are shown in figure 3.2.4.  
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Figure 3.2.3 - Effect of EO treatment on RKO cells on cell viability (serial dilutions 1:10 starting at 1 
µL/mL concentration). Oils used in this study were extracted from the Peniche dune plants A) 
Crithmum maritimum (n=3), B) Seseli tortuosum (n=3), C) Artemisia campestris (n=2), D) Juniperus 
turbinata (n=4), E) Otanthus maritimus (n=4) and F) Eryngium maritimum (n=2). The starting 
concentration of each EO was 1 µL/mL, further serially diluted 1:10 up to 10-6 µl/ml. RKO cells were 
seeded in a 96 well plate at a density 1x104 cells per well and treated with the diluted oil solutions. 
After 72 hours of incubation, an MTS assay was performed for each plate, according to 
manufacturers instructions. Values represent the % of cellular viability as assessed by the MTS 
assay. 
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Figure 3.2.4 - Effect of EO treatment on MCF7 cells on cell viability (serial dilutions 1:10 starting at 
1 µL/mL concentration). Oils used in this study were extracted from the Peniche dune plants A) 
Crithmum maritimum (n=3), B) Seseli tortuosum (n=3), C) Artemisia campestris (n=2), D) Juniperus 
turbinata (n=4), E) Otanthus maritimus (n=4) and F) Eryngium maritimum (n=2). The starting 
concentration of each EO was 1 µL/mL, further serially diluted 1:10 up to 10-6 µl/ml. RKO cells were 
seeded in a 96 well plate at a density 5x103 cells per well and treated with the diluted oil solutions. 
After 72 hours of incubation, an MTS assay was performed for each plate, according to 
manufacturers instructions. Values represent the % of cellular viability as assessed by the MTS 
assay. 
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In serial dilution with a final concentration 1 µL/mL, all the EOs exhibited anti-proliferative 
activity against RKO cells, as shown by a clear decreased in cell viability. Seseli tortu-
osum and Eryngium maritimum EOs induced the highest decrease of cellular viability. 
For MCF7 cell line, the results of MTS assay in the serial dilutions at a starting concentra-
tion of 1 µL/mL are shown in figure 3.2.4. All EOs exhibited a decrease in cellular viability 
against MCF7 cells. Seseli tortuosum, Otanthus maritimus and Eryngium maritimum EOs 
led to the strongest decrease in cellular viability, as is show in figure 3.2.4. 
After the determination of the potential antitumor activity of each EO, by MTS assay, it 
was necessary to calculate the half maximal inhibitory concentration (IC50) values, in order 
to compare more directly the effect of the different EOs, for each cell line. It is important to 
note that the lowest the IC50, the strongest the effect of the drug/EO/compound, and low 
IC50s are desirable due to reduced likeliness of toxicity to non-cancerous tissue (Ganot et 
al. 2013). 
Dose-response curve fitting for all EOs for both cell lines, at a starting concentration of 5 
µL/mL using a dilution 1:2 are displayed in figure 3.2.5. The respective IC50 values are 
shown in table III. 
 
Table III - IC50 mean values (± SD) for Crithmum maritimum, Seseli tortuosum, Artemisia 
campestris, Juniperus turbinata, Otanthus maritimus and Eryngium maritimum EOs from Peniche 
(Portugal), at a final concentration 5 µL/mL with dilution 1:2. To calculate the IC50 values, MTS 
assay was carried out and was performed using the Graph Pad Prism software. 
 
Final concentration 5 µL/mL 
Essential Oil 
Average IC50 (µL/mL) ± SD Number of inter-
experimental re-
peats RKO MCF7 
Crithmum maritimum 8,35E-01 ± 5,31E-01 6,04E-01 ± 3,25E-01 n = 3 
Seseli tortuosum 2,00E-05 ± 1,68E-05 9,69E-06 ± 1,62E-05 n = 3 
Artemisia campestris 4,88E-02 ± 6,90E-02 3,74E-02 ±3,96E-02 n = 2 
Juniperus turbinata  2,65E-01 ± 3,06E-01 4,47E-01 ± 3,89E-01 n = 4 
Otanthus maritimus 1,74E-05 ± 1,19E-05 4,48E-03 ± 6,70E-03 n = 4 
Eryngium maritimum 1,13E+04 ± 1,96E+04 2,35E+04 ± 4,03E+04 n = 3 
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Figure 3.2.5 – Estimated dose-response parameter of each EO tested against RKO and MCF7 
cancer cell lines. The species used were A) Crithmum maritimum, B) Seseli tortuosum, C) 
Artemisia campestris, D) Juniperus turbinata, E) Otanthus maritimus and F) Eryngium maritimum 
Essential Oils, against RKO (●) and MCF7 (■) cell lines viability detected by MTS Assay, at a 
concentration 5 µL/mL and dilution 1:2. MTS assay was carried out as described before (Figures 
3.2.1 and 3.2.2) and Graph pad prism software was used to plot the curve fitting for each oil.  
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When comparing the IC50 values obtained for all EOs tested for the RKO cell line data set, 
Seseli tortuosum, Otanthus maritimus and Artemisia campestris EOs treatment showed 
the highest decrease of cellular viability (as indicated by the lowest IC50), followed by 
Juniperus turbinata (leaves) and Crithmum maritimum EOs (figure 3.2.5 and table III).  
The EOs that shown the highest activity against MCF7 cells (again, as indicated by the 
lowest IC50) were Seseli tortuosum, Otanthus maritimus and Artemisia campestris, 
followed by Juniperus turbinata and Crithmum maritimum EOs. Eryngium maritimum EO 
had the lower activity against MCF7 and RKO cell lines. 
Dose-response curves fitting for all EOs for both cell lines, at a starting concentration of 1 
µL/mL using a dilution 1:10 are displayed in figure 3.2.6. The respective IC50 values are 
shown in table IV. 
 
 
Table IV - IC50 mean values (± SD) for Crithmum maritimum, Seseli tortuosum, Artemisia 
campestris, Juniperus turbinata (leaves), Otanthus maritimus and Eryngium maritimum EOs from 
Peniche (Portugal), at a final concentration 5 µL/mL with dilution 1:2. To calculate the IC50 values, 
MTS assay was carried out and was performed using the Graph Pad Prism software. 
Final concentration 1 µL/mL 
Essential Oil 
Average IC50 (µL/mL) ± SD Number of inter-
experimental 
repeats RKO MCF7 
Crithmum maritimum 8,07E-02 ± 1,26E-01 5,36E-03 ± 7,06E-03 n = 3 
Seseli tortuosum 3,29E-03 ± 2,58E-03 1,85E-03 ±8,38E-04 n = 3 
Artemisia campestris 1,14E-02 ±2,85E-03 9,81E-02 ± 1,28E-01 n = 2 
Juniperus turbinata 5,78E-02 ± 4,35E-02 1,13E-01 ±1,88E-01 n = 4 
Otanthus maritimus 1,52E-02 ± 8,77E-03 1,23E-02 ±4,02E-03 n = 4 
Eryngium maritimum 8,59E-04 ±5,58E-04 2,72E-03 ±2,15E-03 n = 2 
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Figure 3.2.6 – Estimated dose-response parameter of each EO tested against RKO and MCF7 
cancer cell lines. The species used were A) Crithmum maritimum, B) Seseli tortuosum, C) 
Artemisia campestris, D) Juniperus turbinata, E) Otanthus maritimus and F) Eryngium maritimum 
Essential Oils, against RKO (●) and MCF7 (■) cell lines viability detected by MTS Assay, at a 
concentration 1 µL/mL and dilution 1:10. MTS assay was carried out as described before (Figures 
3.2.3 and 3.2.4) and Graph pad prism software was used to plot the curve fitting for each oil.  
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When comparing the IC50 values obtained for all EOs tested for RKO cell line data set, 
Seseli tortuosum, Eryngium maritimum and Crithmum maritimum EOs treatment showed 
the highest decrease of cellular viability (as indicated by the lowest IC50), followed by 
Juniperus turbinata (leaves), Otanthus maritimus and Artemisia campestris EOs (figure 
3.2.6 and table IV). 
The EOs that showed the highest activity against MCF7 cells (again, as indicated by the 
lowest IC50) were Crithmum maritimum, Eryngium maritimum and Seseli tortuosum EOs, 
followed by Artemisia campestris, Otanthus maritimus and Juniperus turbinata (leaves) 
EOs. 
 
3.3 Evaluation of mechanism of biological effects of EOs 
After the evaluation of the efficacy of the EOs extracted in decreasing cancer cell viability 
the EOs from the species that showed the highest potential as anticancer agents (Seseli 
tortuosum and Otanthus maritimus) were selected for a study concerning the mode of 
action. 
Seseli tortuosum EO was diluted to the IC50 concentrations of 6 µL/mL (for RKO cells) and 
8.5 µL/mL (for MCF7), and Otanthus maritimus EO was diluted to the IC50 concentrations 
of 4 µL/mL and 7.5 µL/mL (for RKO and MCF7 cell lines, respectively). DMSO was used 
as a vehicle control. 
 MCF7 and RKO cells were incubated for 8 h, 24 h, 48 h and 72 h with the EO solutions in 
media or vehicle control diluted in media, after which cells were harvested and protein 
expression analysed by Western blotting. The proteins selected for analysis are 
associated biological processes relevant to decreased viability/proliferation in cells, 
namely programmed cell death/apoptosis by looking for cleaved caspase 3, and cell cycle 
arrest and DNA damage response by looking at p21 and p53 expression. β-Actin was 
used as a loading control. 
The results of Western blot technique, for Seseli tortuosum treatment are shown in figure 
3.3.1 and for Otanthus maritimus treatment are shown in figure 3.3.2. 
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Figure 3.3.1 – Western blot analysis for Seseli tortuosum EO treatment in MCF7 (A) and RKO (B). 
MCF7 and RKO cells were treated with 8.5 µL/mL and 6 µL/mL (IC50 values represented in table 
III), respectively. Cells were incubated for 8, 24, 48 and 72 hours before harvesting. Western 
blotting was carried out for p53, p21, cleaved Caspase-3 and β-Actin (loading control). Bar charts 
represent densitometry analysis of the protein bands (y axis) was performed using ImageJ software 
(calculated relative to β-Actin band intensity) for MCF7 (C) and RKO (D) cell lines, of the proteins 
bands in p53 and p21 in treatment (x axis) 1) DMSO at 8 hours (Control); 2) Seseli tortuosum EO 
at 8 hours; 3) DMSO at 24 hours; 4) Seseli tortuosum EO at 24 hours; 5) DMSO at 48 hours; 6) 
Seseli tortuosum at 48 hours; 7) DMSO at 72 hours and 8) Seseli tortuosum at 72 hours 
treatments. 
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Figure 3.3.2 – Western blot analysis for Otanthus maritimus EO treatment in MCF7 (A) and RKO 
(B). MCF7 and RKO cells were treated with 7.5 µL/mL and 4 µL/mL (IC50 values represented in 
table IV), respectively. Cells were incubated for 8, 24, 48 and 72 hours before harvesting. Western 
blotting was carried out for p53, p21, cleaved Caspase-3 and β-Actin (loading control). Bar charts 
represent densitometry analysis of the protein bands (y axis) was performed using ImageJ software 
(calculated relative to β-Actin band intensity) for MCF7 (C) and RKO (D) cell lines, of the proteins 
bands in p53 and p21 in treatment (x axis) 1) DMSO at 8 hours (Control); 2) Otanthus maritimus 
EO at 8 hours; 3) DMSO at 24 hours; 4) Otanthus maritimus EO at 24 hours; 5) DMSO at 48 hours; 
6) Otanthus maritimus at 48 hours; 7) DMSO at 72 hours and 8) Otanthus maritimus at 72 hours 
treatments. 
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Western blot analysis showed that treatment with the Seseli tortuosum EO, in MCF7 cells 
affected the expression of p53, showing a small decrease until treatment 5 (DMSO at 48h) 
and after a small increase. In RKO cell line, the expression of p53 showed a stabilization 
in their amount, except in treatment 5 (DMSO at 48h). 
Treatment with Seseli tortuosum EO affected the expression of p21, leading to an 
increase of p21 amount in MCF7 cells, except in treatment 5 (DMSO at 48 hours). In RKO 
cells the expression of p21 showed a variation in their amount. At 8 hours and 48 hours of 
treatments p21 showed a stabilization in their levels, but at 24 hours and 72 hours, the 
amount of p21 had a small amount followed by an increased amount (DMSO and EO 
treatments, respectively.  
Western blot analysis showed that treatment of MCF7 cells with Otanthus maritimus EO 
affected the expression of p53, leading to an increased in its amount until 72 hours of 
treatment. In RKO cell line, the expression of p53 showed an increase in amount in EO 
treatments than DMSO (vehicle). 
In treatment with the Otanthus maritimus EO, western blot showed that EO affected the 
expression of p21, showing an increase of their amount in EO treatments than DMSO 
(vehicle), by the times tested in MCF7 cells, except at 72 hours of treatment (p21 was not 
observed).  In RKO cells the expression of p21 showed an increase of their amount in EO 
treatments than DMSO (vehicle), by the times tested, and in treatment 6 (EO treatment at 
48 h) the amount showed be very high. 
For Seseli tortuosum and Otanthus maritimus EO treatment of both cancer cell lines 
tested cleaved caspase 3 was not observed. 
In the previous result dataset, it was observed that treatment with Seseli tortuosum EO led 
to an increase in p21 protein level in the first two days of treatment (and to a certain 
degree, this was also observed for Otanthus maritimus EO treatment). Since it is known 
that p21 accumulation could be an indicative of cell cycle arrest (as mentioned in the 
Introduction, section 1.3.2), it was decided to analyse cell cycle progression of both MCF7 
and RKO cells after treatment with Seseli tortuosum EO using Fluorescence-activated cell 
sorting (FACS) to detect changes in DNA content. 
The results regarding the evaluation of the effect of Seseli tortuosum EO treatment in cell 
cycle progression are presented in figure 3.3.3 and table V, for RKO cells, and in figure 
3.3.4 and table VI, for MCF7 cells. 
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Figure 3.3.3 – DNA content histograms from RKO cell line after treatment with Seseli tortuosum. 
RKO cells was treated with 6 µL/mL, respectively, of Seseli tortuosum EO and DMSO (vehicle). 
The cells were incubated for 8, 24, 48 and 72 hours and fixed in 70% ethanol. After PI staining, 
FACS analysis (section 2.11) was done for all samples. Sample key: A) Control; B) DMSO – 8 
hours; C) Seseli tortuosum – 8 hours; D) DMSO for 24h; E) Seseli tortuosum – 24 hours; F) DMSO 
– 48 hours; G) Seseli tortuosum – 48 hours; H) DMSO for 72h; I) Seseli tortuosum – 72 hours. The 
different phases of the cell cycle were represented by M1: G1 Phase; M2- S Phase and M3 – G2 
and M Phase. In the FL2-H (x axis) the intensity of emitted fluorescent from PI (DNA dye) is 
represented, as a surrogate of DNA content. 
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Table V – Flow cytometry analysis of % of cells per stage of the cell cycle in RKO cells treated with 
Seseli tortuosum EO. The different phases of the cell cycle were represented by M1: G1 Phase; 
M2- S Phase and M3 – G2 and M Phase and were obtained from the histograms shown in figure 
3.3.3) 
RKO 
  
 
8 hours 
 
24 hours 
 
48 hours 
 
72 hours 
Phase  Control 
 
DMSO 
Seseli 
tortuosum  
DMSO 
Seseli 
tortuosum  
DMSO 
Seseli 
tortuosum  
DMSO 
Seseli 
tortuosum 
M1 60.29 
 
41.23 32.36 
 
50.16 46.84 
 
57.76 53.30 
 
59.88 57.92 
M2 9.02 
 
13.26 14.43 
 
17.12 17.31 
 
10.61 10.44 
 
9.97 9.65 
M3 25.26   38.17 45.00   26.55 29.37   22.81 26.80   26.55 22.45 
 
In the RKO cell line the percentage of cells in each cell cycle stage, as quantified by 
FACS analysis, is represented in table V. 
The first phase (corresponding to G1 phase) had higher percentage of cells in all 
treatments. By the times tested, it was possible to observe that in G1 phase the 
percentage of cells had increased. The M2 phase, corresponding to S phase, the 
percentage of cells were lower comparing to G1 phase, and by the times points tested, the 
percentage of number of cells decreased, except at 24 hours of treatments (DMSO and 
EO). The percentage of cells in phase G2 is lower than G1 phase, except at 8 hours with 
EO treatment and by the time points tested is possible observe a decrease of the 
percentage of cells, except for DMSO treatment at 72 hours. 
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Figure 3.3.4 - DNA content histograms from MCF7 cell line after treatment with Seseli tortuosum. 
RKO cells was treated with 8.5 µL/mL, respectively, of Seseli tortuosum EO and DMSO (vehicle). 
The cells were incubated for 8, 24, 48 and 72 hours and fixed in 70% ethanol. After PI staining, 
FACS analysis (section 2.11) was done for all samples. Sample key: A) Control; B) DMSO – 8 
hours; C) Seseli tortuosum – 8 hours; D) DMSO for 24h; E) Seseli tortuosum – 24 hours; F) DMSO 
– 48 hours; G) Seseli tortuosum – 48 hours; H) DMSO for 72h; I) Seseli tortuosum – 72 hours. The 
different phases of the cell cycle were represented by M1: G1 Phase; M2- S Phase and M3 – G2 
and M Phase. In the FL2-H (x axis) the intensity of emitted fluorescent from PI (DNA dye) is 
represented, as a surrogate of DNA content. 
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Table VI – Flow cytometry analysis of % of cells per stage of the cell cycle in RKO cells treated with 
Seseli tortuosum EO. The different phases of the cell cycle were represented by M1: G1 Phase; 
M2- S Phase and M3 – G2 and M Phase and were obtained from the histograms shown in figure 
3.3.4) 
 
 
In MCF7 cell line the percentage of cells in each cell cycle stage, as quantified by FACS 
analysis, is represented in table VI. 
The first phase (corresponding to G1 phase) had higher percentage of cells in all 
treatments, except at 8 hours in both treatments (DMSO and EO) and at 72 hours in EO 
treatment. Is possible observe in G1 phase the percentage of cells increased in 8 hours 
and 24 hours, but in 48 hours and 72 hours, this value decreased. The M2 phase, 
corresponding to S phase, the percentage of cells was lower comparing to G1 phase, and 
by the time points tested, the percentage of cells had a decrease, except at 72 hours of 
EO treatment. Relatively to the percentage of cells in phase G2, this value is lower than G1 
phase, except at 8 hours with both treatments and 72 hours in EO treatment. By the time 
points tested is possible to observe a decrease of the percentage of cells. 
MCF7 
  
 
8 hours 
 
24 hours 
 
48 hours 
 
72 hours 
 Phase Control 
 
DMSO 
Seseli 
tortuosum  
DMSO 
Seseli 
tortuosum  
DMSO 
Seseli 
tortuosum  
DMSO 
Seseli 
tortuosum 
M1   
 
38.51 28.96 
 
48.92 39.78 
 
50.85 37.25 
 
71.64 22.98 
M2   
 
13.06 10.03 
 
10.94 8.95 
 
2.86 2.54 
 
3.26 19.78 
M3     39.49 45.20   33.51 35.85   27.30 27.33   19.47 24.80 
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4.1 Overview of this work  
In recent years, the use of aromatic and medicinal plants has increased (Burt 2004; 
Kordali et al. 2005; Gonçalves et al. 2010; Miguel 2010; Chen et al. 2011; Koba et al. 
2011;). Some EOs have also been used in food preservation, aromatherapy and 
fragrance industries and other oils have been used in cancer treatment (Sharma et al. 
2009; Sylvestre et al. 2006; Kapoor et al. 2008; Cooke & Ernst 2000; Carnesecchi et al. 
2001). 
In this study, EOs of the six selected species – Artemisia campestris subsp. maritima 
Crithmum maritimum; Eryngium maritimum; Juniperus turbinata subsp. turbinata; 
Otanthus maritimus and Seseli tortuosum - were investigated in order to determine their 
efficacy as potential cytotoxic/cytostatic agents in human breast adenocarcinoma (MCF7) 
and colorectal carcinoma (RKO) cell line models. 
As shown in section 3.2, treatment with all EOs tested led to a decrease in cellular viability 
for both cell lines tested (as measured by MTS assay). The only exception was for the 
effect of treatment with Eryngium maritimum EO (1:2 dilution starting at a concentration of 
5 µL/mL). 
In order to realise if the reduction in cell viability is concentration-dependent, and in 
particular for achieving compare the potency of the effects demonstrated by the various 
EOs studied, it was decided to carry out a test concentration dependence for each EO, 
showing a reduction in capacity less than 50% in different tested concentrations of 5 
µL/mL (figure 3.2.5) and 1 µL/mL (figure 3.2.6). The lowest IC50 values represent the EOs 
that need a lower concentration to administer and obtain a stronger effect in cells tested. 
Instead, the highest IC50 values obtained represent a required highest concentration of the 
EO to obtain a stronger effect in MCF7 and RKO cells. 
As showned in table III, for RKO cell line, Seseli tortuosum, Otanthus maritimus and 
Artemisia campestris subsp. maritima EOs presented the lowest IC50 values. Juniperus 
turbinata subsp. turbinata (leaves) and Crithmum maritimum EOs presented the highest 
IC50 values, for RKO cell line (table III). Eryngium maritimum EO obtained an IC50 value 
too high. For MCF7 cell line, represented in table III, Seseli tortuosum, Otanthus 
maritimus and Artemisia campestris subsp. maritima EOs had the lowest IC50 values. 
Namely, Juniperus turbinata subsp. turbinata and Crithmum maritimum EOs had the 
highest IC50 values. Eryngium maritimum EO had an IC50 value very high.  
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As reported in table IV, relative to RKO cell line, Seseli tortuosum, Eryngium maritimum 
and Crithmum maritimum EOs had the lowest IC50 values. Conversely, Juniperus 
turbinata subsp. turbinata (leaves), Otanthus maritimus and Artemisia campestris subsp. 
maritima EOs obtained the highest IC50 values. In MCF7 cell line, Crithmum maritimum, 
Eryngium maritimum and Seseli tortuosum EOs showed the lowest values and Artemisia 
campestris subsp. maritima, Otanthus maritimus and Juniperus turbinata subsp. turbinata 
(leaves) EOs obtained the highest IC50 values. 
In section 3.3 the mechanism of action of selected EOs (Seseli tortuosum and Otanthus 
maritimus) was explored by western blot, using the determined IC50 values, in order to 
understand which mechanisms that EOs follow to inhibit cellular viability/proliferation. This 
study revealed that p53 was activated by cellular stress and not by programmed cell 
death, as cleaved caspase 3 was not observed. p21 was observed in present study, and 
to comprove the results, FACS was performed concluding that EOs tested possibly had a 
potential to induce cell cycle arrest, namely in G1 phase. 
 
4.2 Chemical composition of EOs tested 
In the present study, EO extraction led to yields ranging from 0.08% to 0.66%, depending 
on the species. A wide range of compounds were identified above 10% concentration 
(compounds with a reasonable concentration), except for Eryngium maritimum EO. Main 
constituents were summarised in table I. 
Different major compounds in each species studied are represented in table VII. This table 
allowed a comparison between different studies and major compounds in present study. 
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Table VII – Major constituent(s) for each specie studied with respective author and year of relevant 
studies. 
Species 
Major constituent(s) in 
present study 
Major constituent(s) 
Plant part(s) 
used / Extrac-
tion technique 
Relevante  
Reference 
Artemisia campestris 
β-pinene and Sesquiterpe-
nes 
β-pinene, Limonene and Ger-
macrene D 
Aerial parts/ 
Hydrodistillation 
Akrout et al. 2011 
Crithmum maritimum 
γ-terpinene, Thymol methyl 
ether and Sabinene 
p-cymene, β-phellandrene, γ-
terpinene, Thymol methyl ether 
and dillapiole 
Aerial parts/ 
Supercritical 
CO2 Extraction 
Marongiu et al. 
2007 
Eryngium maritimum 
Germacrene D and other 
Sesquiterpene hidrocarbons  
Germacrene D, 4bH- cadin-9-
en-15-al, 4bH-cadin-9-en-15-ol 
and 4bH-muurol-9-en-15-al  
Aerial parts/ 
Hydrodistillation 
Darriet et al. 2014 
Juniperus turbinata 
α-pinene, β-phellandrene 
and α-terpinyl acetate 
α-pinene, β-phellandrene and 
α-terpinyl acetate 
Leaves/ Hydro-
distillation 
Cavaleiro et al. 
2006 
Otanthus maritimus 
Filifolone, Chrysanthenone 
and cis-chrysantenyl ace-
tate 
Chrysanthenone, Filifolone and 
cis-chrysantenyl acetate  
Aerial parts/ 
Hydrodistillation 
Cabral et al. 2013 
Seseli tortuosum 
α-pinene, β-pinene and (Z)- 
β -ocimene 
α–pinene, β-pinene and (Z)- β-
ocimene  
Ripe Umbles 
with mature 
seeds/ Hydro-
distillation 
Gonçalves et al. 
2012 
 
In the present study, Artemisia campestris subsp. maritima EO was identified to be pre-
dominantly composed of β-pinene (monoterpene) and sesquiterpenes. In another study 
based in Tunisia (table VII), Artemisia campestris subsp. maritima was characterized by 
Akrout and collaborators as having as main compounds β-pinene (monoterpene) (34.2%), 
limonene (monoterpene) (8.2%) and germacrene D (sesquiterpene) (7.3%). The authors 
reported in this EO monoterpene hydrocarbons as the more representative group (72.2%) 
followed by sesquiterpene hydrocarbons (15%) (Akrout et al. 2011). Comparing to Artemi-
sia campestris subsp. maritima study from Portugal, β-pinene is the major compound, and 
the sesquiterpenes were present in both species in highest concentrations. 
The EO extracted from Crithmum maritimum was shown to be composed primarily by γ-
terpinene, thymol methyl ether and sabinene. Marongiu and colleagues investigated the 
chemical composition of this species harvested in Buggerru (Sardinia Island, Italy), Figuei-
ra da Foz (Portugal), and S. Pedro de Moel (Portugal). The authors reported the major 
compounds to be p-cymene, β-phellandrene, γ-terpinene, thymol methyl ether and dillapi-
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ole (Marongiu et al. 2007). This is in accordance to the composition of Crithmum mariti-
mum EO extracted from Peniche in the present study, where γ-terpinene and thymol me-
thyl ether were present in high concentration. 
The EO extracted from Eryngium maritimum was identified in the present study as having 
lower yield, with several compounds below 10% concentration. The main compounds ob-
served were germacrene D (sesquiterpene), as well as other sesquiterpene hidrocarbons. 
In another study, EO extracted from Eryngium maritimum from Corsica had as main com-
ponents germacrene D (33.9%), 4bH- cadin-9-en-15-al (26.1%), 4bH-cadin-9-en-15-ol 
(9.5%) and 4bH-muurol-9-en-15-al (5.2%) (Darriet et al. 2014). Comparing to Eryngium 
maritimum EO from Peniche, gremacrene D is the only compound found in both species. 
In the present study, the EO mixture extracted from Juniperus turbinata subsp. turbinata 
contained α-pinene, β-phellandrene and α-terpinyl acetate as main compounds, all pre-
sent in concentration over 10%. When compared to the composition described by Cavalei-
ro et al. (2006), of Juniperus turbinata subsp. turbinata (also collected in Portugal), the 
sample collected for this study has similar compounds, namely, α-pinene (48.2%), β-
phellandrene (23.1%) and α-terpinyl acetate (5.6%) (Cavaleiro et al. 2006).  
The extracted EO mixture composition for Otanthus maritimus from Quiaios beach, 
Figueira da Foz, Comporta beach and Baleal beach (Portugal) were previously investigat-
ed in the study by Cabral et al. in 2013. There, it was reported that there was no signifi-
cant difference in chemical composition of EOs extracted from specimens harvested in the 
different locations, and the main compounds were the same for all EO mixtures, namely 
chrysanthenone (40.4–57.2%), filifolone (12.2–15.5%) and cis-chrysantenyl acetate (10.1 
– 11.2%) (Cabral et al. 2013). Importantly, the EOs extracted from the specimens collect-
ed for the present study (Consolação beach, Peniche, Portugal) had a similar chemical 
composition. 
The chemical composition of Seseli tortuosum EOs was previously studied by Gonçalves 
and collaborators, in 2012 (Gonçalves et al. 2012). The study reported that Seseli tortu-
osum EOs from two different locations, Vieira de Leiria (Portugal) and Baleal (Portugal), 
had as major constituents α–pinene (24.9% and 24.8%, respectively), β-pinene (23.9% 
and 23.5%, respectively) and (Z)-β-ocimene (13.3% and 16.0%, respectively). Seseli tor-
tuosum EO extracted from specimens harvested at Consolação beach (Peniche, Portugal) 
for the present study revealed a similar composition as reported by Gonçalves et al. 
(2012).  
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Biological activity of EOs may be due to one of the compounds presents in their chemical 
composition or due to the entire mixture. Effects of different classes of compounds pre-
sent in essential oils together with their major properties and their potential therapeutic 
activities are described: 
α–pinene, β-pinene, γ-terpinene, sabinene, germacrene D, p-cymene, β-phellandrene, 
(Z)-β-ocimene and limonene are example compounds of hydrocarbons category. This 
category is characterized to contain molecules of hydrogen and carbon only, and are 
classified into terpenes (mono-, sesqui-, and diterpenes) (Bakkali et al. 2008; Adorjan & 
Buchbauer, 2010; Djilani & Dicko 2010). The hydrocarbons may be acyclic, alicyclic 
(mono-, bi- and tricyclic) or aromatic. These compounds have been associated with vari-
ous therapeutic activities as antiviral, antitumor, antibacterial and hepatoprotective (Bak-
kali et al. 2008; Adorjan & Buchbauer, 2010; Djilani & Dicko 2010). 
Phenols are aromatic components. These compounds are among the most reactive, po-
tentially toxic and irritant, especially for the skin and the mucous membranes. They pos-
sess antimicrobial, rubefacient properties, stimulate the immune and nervous systems and 
may reduce cholesterol (Bakkali et al. 2008; Adorjan & Buchbauer, 2010; Djilani & Dicko 
2010). Phenols are often found as crystals at room temperature, and the most common 
ones are thymol, eugenol, carvacrol and chavicol (Djilani & Dicko 2010). 
Esters are sweet smelling and give a pleasant smell to the oils and are very commonly 
found in a large number of EOs. They include for example, α-terpinyl acetate, cis-
chrysantenyl acetate, linalyl acetate, geraniol acetate, eugenol acetate and bornyl acetate. 
Esters are anti-inflammatory, spasmolytic, sedative, and antifungal (Bakkali et al. 2008; 
Adorjan & Buchbauer, 2010; Djilani & Dicko 2010). 
Oxides or cyclic ethers are the strongest odorants, and by far the most known oxide is 
1,8- cineole, as it is the most omnipresent one in essential oils. Other examples of oxides 
are bisabolone oxide, linalool oxide, sclareol oxide and ascaridole. Their therapeutic bene-
fits are expectorant and stimulant of nervous system (Bakkali et al. 2008; Adorjan & 
Buchbauer, 2010; Djilani & Dicko 2010). In present study any of this compounds category 
was described in any specie. 
Lactones are of relatively high molecular weight and are usually found in pressed oils. 
Some examples of lactones are nepetalactone, bergaptene, costuslactone, dihydronep-
etalactone, alantrolactone, epinepetalactone, aesculatine, citroptene, and psoralen (Ador-
jan & Buchbauer, 2010; Djilani & Dicko 2010). They may be used for antipyretic, sedative 
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and hypotensive purposes, but their contraindication is allergy, especially such involving 
the skin (Bakkali et al. 2008; Adorjan & Buchbauer, 2010; Djilani & Dicko 2010). In this 
study was not reported any of this compounds of this category. 
In addition to their pleasant fragrance, alcohols are the most therapeutically beneficial of 
essential oil components with no reported contraindications. They are antimicrobial, anti-
septic, tonifying, balancing and spasmolytic (Adorjan & Buchbauer, 2010; Djilani & Dicko 
2010). Examples of EO alcohols are linalol, menthol, borneol, santalol, nerol, citronellol 
and geraniol (Adorjan & Buchbauer, 2010; Djilani & Dicko 2010). In present study, any of 
this compounds was reported. 
Aldehydes are common EO components that are unstable and oxidize easily. Many al-
dehydes are mucous membrane irritants and are skin sensitizers (Bakkali et al. 2008; 
Adorjan & Buchbauer, 2010; Djilani & Dicko 2010). They have characteristically sweet, 
pleasant fruity odours and are found in some culinary herbs such as cumin and cinnamon. 
Therapeutically, certain aldehydes have been described as: antiviral, antimicrobial, tonic, 
vasodilators, hypotensive, calming, antipyretic and spasmolytic (Adorjan & Buchbauer, 
2010; Djilani & Dicko 2010). Common examples of aldehydes in EOs include citral (gera-
nial and neral), myrtenal, cuminaldehyde, citronellal, cinnamaldehyde, benzaldehyde 
(Djilani & Dicko 2010) and any of this compounds were reported, in present study. 
Ketones are not very common in the majority of EOs; they are relatively stable molecules 
and are not particularly important as fragrances or flavor substances (Djilani & Dicko 
2010). They may be mucolytic, cell regenerating; sedative, antiviral, analgesic and diges-
tive. Due to their stability, ketones are not easily metabolized by the liver (Adorjan & 
Buchbauer, 2010; Djilani & Dicko 2010). Common examples of ketones found in EOs in-
clude carvone, menthone, pulegone, fenchone, camphor, thujone and verbenone (Bakkali 
et al. 2008; Adorjan & Buchbauer, 2010; Djilani & Dicko 2010). Any of this EOs com-
pounds were described in this study. 
 
4.3 Cell viability assessment by MTS Assay 
Evaluation of the anticancer activity of exposure to EOs can be achieved by the MTS as-
say. The MTS assay is a colorimetric viability assay based on enzymatic reduction of the 
MTS molecule to formazan when it is exposed to viable cells. The outcome of the reduc-
tion is a colour change of the MTS molecule. Absorbance measurements relative to a con-
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trol determine the percentage of remaining viable cancer cells following their treatment 
with varying concentrations of a tested EO, which is translated to the EO anticancer activi-
ty and its IC50 values. 
All the EOs exhibited anticancer activity against RKO and MCF7 cells, as shown by a 
clear decrease in cell viability, as measured by the MTS assay and by IC50 values calcu-
lated. 
 
4.3.1 Crithmum maritimum L. 
Treatment with Crithmum maritimum EO at a concentration 5 µL/mL (figure 3.2.1 A and 
3.2.2 A), led to a decrease in cellular viability, however at this concentration, EOs treat-
ments were highly toxic for both cell lines, and were not suitable for accurate determina-
tion of the IC50s. The maximum concentration tested in vitro should be until 100% of the 
cells in tests lose their completely cellular activity (not more than that). This way, the dose-
response of the EO/compound/drug, and sub consequently IC50 values, calculated 
through by MTS assay (as in present study) will be more efficiently and correctly. As is 
possible to observe, at 5 µL/mL concentration, in MTS assay results and IC50 values, the 
cellular viability was below of 0% cellular viability. Therefore, it was decided to repeat the 
experiments using serial dilutions 1:10 at a starting concentration 1 µL/mL.  
At a final concentration 1 µL/mL with a dilution 1:10, Crithmum maritimum EOs treatment, 
again led to a decrease in cellular viability (figure 3.2.3 A and 3.2.4 A). That suggests the 
EOs from this species have potential anticancer properties. 
Comparing to a final concentration 5 µL/mL with a dilution 1:2, Crithmum maritimum EO 
treatment in the serial dilutions, at a final concentration 1 µL/mL had lower IC50 values. 
The IC50 values in this concentration were 8.07E-02 µL/mL and 5.36E-03 µL/mL for RKO 
and MCF7 cell lines, respectively (figure 3.2.6 A and table III).  These values allow us to 
compare how the cell viability is affected by dilution of the concentration of essential oils. 
Is possible to conclude that a lower maximal concentration is necessary to decrease via-
bility in 50% of cell culture, in vitro. 
Various authors have studied the effects of C. maritimum EO in several aspects of cell 
biology, uncovering antioxidant and antibiotic activities (Jallali et al. 2014; Meot-Duros et 
al. 2008; Meot-Duros & Magné 2009). However, to our knowledge, studies are scarce 
regarding any potential anticancer properties. One study, by Meot-Duros and collabora-
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tors reported that falcarindiol showed cytotoxicity against IEC-6 (normal rat small intes-
tine) cells with an IC50 value of 20 µM after 48 h of exposition (Meot-Duros et al. 2010). 
Falcarindiol is a compound reported in Crithmum maritimum that exhibits various biologi-
cal properties, such as antibacterial and anti-mutagenic properties (Meot-Duros et al. 
2010; Jin et al. 2012; Jallali et al. 2014). However, Meot-Duros isolated this compound by 
solvent extraction. By hydrodistillation, the isolation of this compound is difficult to per-
form. This compound was not found in the chemical composition in Crithmum maritimum 
EO from Peniche. 
 
4.3.2 Seseli tortuosum L. 
At a final concentration 5 µL/mL, Seseli tortuosum EO treatment had a significant de-
crease in cellular viability, in RKO (figure 3.2.1 B) and MCF7 (figure 3.2.2 B) cell lines. 
The cellular viability decrease proved to be very pronounced. Because of this situation 
serial dilutions were performed at starting concentration 1 µL/mL and dilution 1:10. 
In concentration 1 µL/mL (figure 3.2.3 B and 3.2.4 B), the IC50 values were higher than the 
concentration 5 µL/mL, namely, the IC50 values for RKO and MCF7 cells are 3.29E-03 
µL/mL and 1.85E-03 µL/mL, respectively (figure 3.2.6 B and table III).  It is possible to 
conclude that a lower maximal concentration was necessary to decrease viability in 50% 
of cell culture, in vitro, when tested at starting final concentration 5 µL/mL. 
Gonçalves and colleagues investigated the cytotoxic properties in human keratinocytes 
(HaCaT) cell line with Seseli tortuosum EO, at different concentrations – 0.32 µL/mL; 0.64 
µL/mL and 1.25 µL/mL (Gonçalves et al. 2012). It was showed in this study that Seseli 
tortuosum EOs had a cytotoxic effect on human keratinocytes, especially when used in 
concentrations above 0.64 µL/mL. The authors suggested the attention for the application 
of the oil for health promoter activities, specifically in the selection of concentrations with 
fungicidal activity and without cytotoxicity (Gonçalves et al. 2012). The results in the pre-
sent study are in agreement with results shown by Gonçalves and collaborators, as in 
both studies at 0.64 µL/mL the cellular viability had a clear decrease. However, a de-
crease in cellular viability was observed at lower concentrations than the ones used in 
Gonçalves et al. 2012, indicating that Seseli tortuosum EOs contain compounds that can 
decrease viability in cancer cell lines and that these are more sensitive to the EOs than 
primary cells (such as the keratinocytes). 
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4.3.3. Artemisia campestris subsp. maritima (DC.) Arcang. 
Treatment with Artemisia campestris subsp. maritima EO treatment led to a decrease in 
cellular viability in both RKO and MCF7 cell lines, for final concentration range tested, at 5 
µL/mL (figures 3.2.1 C and 3.2.2 C, respectively). However, at this range this EO treat-
ment showed to be toxic to cancer cell lines tested. For this reason, the same treatment 
was performed with different starting final concentration 1 µL/mL and dilution 1:10. 
The cellular viability are reported in figures 3.2.3 C and 3.2.4 C for RKO and MCF7, re-
spectively. The IC50 values are 1.14E-02 µL/mL and 9.81E-02 µL/mL in RKO and MCF7 
cell lines, respectively, at a final concentration 1 µL/mL in a dilution 1:10 (figure 3.2.6 C 
and table III). Comparing both concentrations tested, RKO cell line had a decrease in cel-
lular viability as expected (comparison between 5 µL/mL and 1 µL/mL). However, MCF7 
cell line had a small increase in cellular viability (as proved by IC50 values), which was not 
expected. Thus indicates, that for RKO cell line a lower maximal concentration was nec-
essary to decrease viability in 50% of cell culture, in vitro. But, for MCF7 cell line, the max-
imal concentration to inhibit viability to half needs to be higher. Comparing to other EOs 
treatments tested, Artemisia campestris subsp. maritima had the lower number of inter-
replicas (n=2). To confirm this results, more inter-experimental replicas should be done.  
Whilst there are many studies demonstrating antioxidant properties for A. campestris ex-
tracts (Aniya et al. 2000; Djeridane et al. 2006), the literature regarding possible anti-
tumour action is scarce (Kaneshiro et al. 2005). EOs extracted from Artemisia campestris 
L. from southern Tunisia using ethanol-water (EtOH), hexane extract and infusion extract 
approaches were investigated by Akrout and colleagues (Akrout et al. 2011) The authors 
investigated the antitumor activity of EOs from this species against human colon cancer 
(HT-29) cell line using MTT assay to determine net growth inhibition. Akrout and collabo-
rators showed the most significant growth inhibitory action was performed by Artemisia 
campestris L. EO (comparing to EtOH and hexane extracts) with a GI50 (estimation of 
growth inhibition of 50%) value 46.82 µg/mL, while EtOH presented a GI50 value higher 
than 100 µg/mL and the hexane extracts presented a GI50 value higher that 1920 µg/mL 
(Akrout et al. 2011). Akrout et al. described that Artemisia campestris EOs contained high 
concentration of β-pinene, α-pinene and germacrene D, myrcene and limonene – all ter-
penes, which have been described by their antitumor activity against several types of hu-
man cancers, such as breast cancer, liver cancer and melanoma (Li et al. 2009; Darmanin 
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et al. 2009; Crowell 1999). A hypothesis proposed by Akrout and his collaborators is that 
terpenes might be responsible for all or part of the antitumor activity (Akrout et al. 2011). 
Importantly, these compounds were present in Artemisia campestris subsp. maritima EO 
harvested from Peniche and used in the present study.  
 
4.3.4 Juniperus turbinata Guss. subsp. turbinata 
For both final concentrations used - 5 µL/mL (figure 3.2.1 D and 3.2.2 D) and 1 µL/mL 
(figure 3.2.3 D and 3.2.4 D) – treatment with Juniperus turbinata subsp. turbinata EO lead 
a decrease in cellular viability for both cell lines, as indicated by IC50 values demonstrated. 
However, Juniperus turbinata subsp. turbinata EO proved to be toxic to cancer cell lines 
tested. 
At a final concentration 1 µL/mL (figure 3.2.6 D and table III), the IC50 values were 5.78E-
02 µL/mL and 1.13E-01 µL/mL for RKO and MCF7, respectively. This values indicates 
that was necessary a lower maximal concentration to decrease viability in 50% of cell 
culture, in vitro, at starting final concentration 1 µL/mL. 
Until present, to our knowledge there are no published works on the anticancer activity of 
Juniperus turbinata subsp. turbinata. However, this EO had in your chemical composition, 
as reported above, as major compounds α-pinene, β-phellandrene. These compounds 
have been reported as anticancer properties (Bowles 2003; Edris 2007; Djilani & Dicko 
2010). Akrout and collaborators reported too that terpenes, compounds present in 
Juniperus turbinata subsp. turbinata EO from Peniche, could be responsible for all or part 
of the antitumor activity in diverse types of human cancer (Akrout et al. 2011). 
 
4.3.5 Otanthus maritimus (L.) Hoffmans. & Link 
Treatment with Otanthus maritimus EO led to a decrease in cellular viability in both RKO 
and MCF7 cell lines at starting final concentration 5 µL/mL (figure 3.2.1 E and 3.2.2 E). 
This concentration of Otanthus maritimus EO showed to be very toxic in cancer cell lines 
tested. For this reason EO was tested in RKO and MCF7 at different concentration, name-
ly, 1 µL/mL (figure 3.2.3 E and 3.2.4 E). 
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IC50 values diversify between concentrations tested, namely for 1 µL/mL the IC50 values 
were 1.52E-02 and 1.23E-02 (figure 3.2.6 E and table III). The activity EO from Otanthus 
maritimus was investigated regarding several different biological properties, as reported 
(Agias et al. 2005; Basile et al. 2013). To our knowledge there are no published works on 
the anticancer activity of this oil. However, as reported by Akrout and collaborators, ter-
penes, compounds present above 10% (of total concentration) in Otanthus maritimus EO 
from Peniche, might be responsible for all or part of the antitumor activity in diverse types 
of human cancer (Akrout et al. 2011; Li et al. 2009; Darmanin et al. 2009; Crowell 1999). 
 
4.3.6 Eryngium maritimum L. 
Exposure to Eryngium maritimum EO treatment at a concentration of 5 µL/mL (figure 3.2.1 
F and 3.2.2 F), mediated an increase in cellular viability, which indicating that cellular in-
tegrity was not compromised, was not expected. The most significant increase in cellular 
viability was shown by MCF7 cell line comparing to RKO cell line (figure 3.2.5 F and table 
II).  
For a starting concentration of 1 µL/mL with a dilution of 1:10, Eryngium maritimum EO 
treatment, showed a decrease in cellular viability (figure 3.2.3 F and 3.2.4 F), as expected. 
This suggests this EO to have some anticancer properties but only at the lower concentra-
tions tested. Comparing to a final concentration of 5 µL/mL with a dilution of 1:2, Eryngium 
maritimum EO treatment in the serial dilutions, at a final concentration 1 µL/mL had clearly 
lower IC50 values. The IC50 values determined for this dilution range were 8.59E-04 µL/mL 
and 2.72E-03 µL/mL for RKO and MCF7 cell lines, respectively (figure 3.2.6 F and table 
III). The difference between this concentrations tested are very high showing this EO was 
not properly indicated for a complement in cancer therapy. Eryngium maritimum EO 
showed to be a viscous liquid from the start of these studies and difficult to dilute in the 
chosen vehicle, DMSO, and medium. Due to these issues, further research with more 
inter-experimental replicas should be performed. 
Studies regarding Eryngium maritimum EOs extraction are very scarce. However, Eryngi-
um maritimum EOs have been investigated regarding its anti-inflammatory, antinocicep-
tive  antioxidant,  antimicrobial, antimalarial and antileishmanial activity (Darriet et al. 
2014; Meot-Duros et al. 2008; Küpeli et al. 2006; Fokialakis et al. 2006). This plant extract 
have been studied, and Yurdakök & Baydan investigated cytotoxic effect in two species 
from plant extracts belonging to Eryngium L. genus, among them, the species Eryngium 
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maritimum. The aerial and roots parts of the plant were harvested from Balikesir (Turkey) 
and lyophilized. Anticancer properties of the EOs extracted from this species were tested 
on human hepatocellular carcinoma (HepG2) and human laryngeal epidermoid carcinoma 
(Hep2) cell models. The range of concentrations tested were between 8.33 and 266.62 
mg/mL. Yurdakök & Baydan in this study, used different cell viability techniques compar-
ing to the present work, namely, they analysed the cytotoxic effect by lactate dehydrogen-
ase (LDH) leakage and MTT cell viability assays. They reported that Eryngium maritimum 
exhibited cytotoxic effect in Hep2 cell line with IC50 values for root parts of 30.25 mg/mL 
and in HepG2 cell line for aerial and root parts of 32.42 and 35.01 mg/mL, respectively. 
They concluded the EOs extracted from this species had cytotoxic activity against cell 
lines described, and therefore, potential promising anticancer properties. However, further 
analysis is needed to confirm this activity (Yurdakök & Baydan 2013).  
 
Comparing the activity of the EOs extracted for all the species tested in this study, the 
EOs from Seseli tortuosum, Otanthus maritimus and Artemisia campestris subsp. 
maritima mediated the highest efficacy in decreasing cellular viability (by MTS assay), as 
noted by the lower IC50 values. Other EOs – Crithmum maritimum, Juniperus turbinata 
subsp. turbinata and Eryngium maritimum – also showed a decrease in cellular viability in 
both concentrations tested - except Eryngium maritimum (just in 1 µL/mL) - however, the 
IC50 values were higher. The EO from Eryngium maritimum plant was the only that 
showed a substantial increase in cellular viability, when tested at final concentration 5 
µL/mL.  
As cellular viability decreased, for the EOs and concentrations already reported, this could 
indicate that cellular integrity may have been compromised by different mechanisms. In 
this situation, the plasma membrane integrity could be damaged, the structure of nucleus 
could change and chromatin could have been condensed, and to prove this, it would be 
interesting to study the cellular structure and the chromatin condensation, in order to 
realize if the mechanism responsible for the decrease of cellular viability is apoptosis, 
necrosis, or autophagy. 
The previous suggest the EOs extracted from Seseli tortuosum, Otanthus maritimus and 
Artemisia campestris subsp. maritima EOs extracted from these species, by presenting a 
clear decrease in cellular viability, could be used in future complements of health 
applications, as medicaments for example. However, further research is necessary to 
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confirm this. More repeats should be done, since the inter-experimental replicas in this 
study were variable for each EOs tested. In dose-response parameter and IC50 values it 
was observed that the variability of the data were high. Increasing the inter-experimental 
replicas for each EOs mixture would be expected to reduce the variability of the data 
associated in each EO for both cancer cell lines. 
 
4.4 Viability determination methodologies in experimental cancer biology 
Viability cell-based assays are often used for screening collections of compounds to de-
termine if the tested molecules have effects on cell proliferation (Riss et al. 2004). Cell-
based assays that estimate the number of viable eukaryotic cells are also widely used for 
measuring receptor binding and a variety of signal transduction events that may involve 
the expression of genetic reporters, trafficking of cellular components, or monitoring orga-
nelle function (Riss et al. 2004). In vitro cultured cells exist as a heterogeneous popula-
tion. When populations of cells are exposed to test compounds they do not all respond 
simultaneously (Riss et al. 2003). Cells exposed to drug/compound may respond over the 
course of several hours, depending on many factors including the mechanism of cell 
death, the concentration of the drug/compound, and the time of exposure (Riss et al. 
2003). As a result of culture heterogeneity, the data from most plate-based assay formats 
represent an average of the signal from the population of cells (Riss et al. 2003). 
The MTS assay was used to determine cell viability in MCF7 and RKO cell lines. The ma-
jor advantages of MTS assay are the ability to measure cell number without having to dis-
turb the cells by the removal of the experimental culture medium, and, comparing to MTT 
(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay, MTS assay does 
not require prior formazan solubilisation (Riss et al. 2004). However, the MTS assay has 
some disadvantages, as requiring a time of incubation (between 1 and 4 hours), after 4/5 
hours becomes toxic to cells (not so toxic than MTT assay), have interference by reducing 
compounds, limited sensitivity, and the kits are expensive (Riss et al. 2004). 
Huang and collaborators determined that MTS assay, in culture medium, had a variety of 
interacting factors when absorbance is read (Huang et al. 2004). They tested the influence 
of culture medium, the presence of FBS and the concentration of albumin (present in se-
rum). In this study, Huang and collaborators determined: (1) RPMI medium contributed 
either to the activity/viability of the cells during the assay or the amount of formazan pro-
duced; (2) 2% FBS reduced the RPMI response (as opposed to RPMI without FBS com-
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plementary) suggesting mitochondrial activity in DPBS was significantly enhanced by 2% 
serum and (3) albumin present in 10% serum can reduce the assay absorbance by 50% 
(doubling of cell number can be obscured) depending on the concentration of fatty acids. 
Other cell-based assays, as cell-based assays for detecting cytotoxicity in cells in vitro 
could be used instead cell viability assays (Fotakis & Timbrell 2006). Cytotoxicity activity 
leads to a reduction in cell viability and initiates cell death through necrosis and/or 
apoptosis (Fotakis & Timbrell 2006). However, with cytotoxic assays it was only possible 
detect the cytotoxic potential of a test substance (Fotakis & Timbrell 2006). In case the 
aim was differentiate between necrotic and apoptotic processes, further assays should be 
used to follow possible membrane damage, for example, in cytosolic enzymes (lactate 
dehydrogenase – LDH - or dead-cell protease) (Fotakis & Timbrell 2006). 
 
4.5 Study the mode of action of EOs 
Hanahan and Weinberg argued that the most fundamental trait of cancer cells involves 
their ability to sustain chronic proliferation (Hanahan & Weinberg 2011). Normal tissues 
carefully control the production and release of growth-promoting signals that instruct entry 
into and progression through the cell growth-and-division cycle, thereby ensuring a 
homeostasis of cell number and thus maintenance of normal tissue architecture and 
function. In order for the cell to follow the pathway to become cancerous, it must acquire 
six unique traits (figure 4.5.1) as a result of altered cell physiology (Hanahan & Weinberg 
2011). 
These defining traits of cancer cells are: (1) the ability to generate their own growth 
signals or respond to weak growth signals that are ignored by healthy cells; (2) 
insensitivity to anti-proliferative signals; (3) resistance to cellular suicide mechanisms that 
normally cause aberrant cells to die by apoptosis; (4) the capacity for limitless replication; 
(5) the ability to stimulate new blood vessel development in order to allow for tumour 
growth; and (6) the capacity to invade tissues, at first locally, and later to spread or 
metastasise throughout the body (Hanahan & Weinberg 2011).  
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Figure 4.5.1 – The six hallmarks of cancer proposed by Hanahan and Weinberg (Hanahan & 
Weinberg 2011). 
 
So far, there is no study that can give a clear idea regarding the mode of action of the 
EOs field. Given the complexity of their chemical composition, it is suggested that this 
mode of action is complex, and it is difficult to identify the molecular pathway of action. 
Because of the scarce of studies in this field, this work will help to understand the different 
pathways that EOs could use to decrease cellular viability/proliferation. 
 
4.5.1 Mechanism of action of Seseli tortuosum and Otanthus maritimus EOs 
Stresses, both intrinsic and extrinsic to the cell, can act upon the p53 pathway (Harris & 
Levine 2005).  Among the signals that activate the p53 transcription factor is damage to 
the integrity of the DNA (Harris & Levine 2005). Once p53 is stabilised and activated, it 
initiates a transcriptional program that reflects the nature of the stress signal, such as cell 
cycle arrest, cellular senescence or apoptosis (Harris & Levine 2005) (figure 4.5.1.1). 
A major player in the p53 mediated G1 arrest is the p21 gene product that inhibits cyclin E-
cdk2 (Harris & Levine 2005). This cyclin-dependent kinase acts upon the Rb protein to 
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derepress the E2F1 activity that promotes the transcription of genes involved in preparing 
a cell to progress from G1 to S phase in the cell cycle (Harris & Levine 2005). The p53 
induced G2 arrest is mediated in part by the synthesis of 14-3-3σ, a protein that binds to 
Cdc25C and keeps it in the cell cytoplasm. Cdc25C is a phosphatase that acts upon cyclin 
B-Cdc2, a kinase that is essential for the G2 to M phase transition. Keeping Cdc25C in the 
cytoplasm prevents it from activating cyclin B-Cdc2 in the nucleus and these cells are 
blocked in the G2/M phase of the cell cycle (Harris & Levine 2005).  
After verifying that the EOs extracted from the dune plants from Peniche showed a 
decrease in cellular viability, two species that demonstrated the clearest potential 
anticancer activity were chosen for the study of their mechanism of action. Initially, 
Western blot technique was used to investigate the effects of the EOs on known changes 
in specific proteins that are associated in biological processes. Specifically, changes in 
caspase 3 cleavage (for programmed cell death/apoptosis), and p21 and p53 expression 
(associated with cell cycle arrest and the induction of the DNA damage response) were 
investigated. 
Caspases (cysteinyl aspartate-specific proteases) are a family of important signalling mol-
ecules with various tasks depending on the subtype and organ involved (Green 2000). 
Although the precise role in the initiation and progression of apoptosis is not known for all 
caspases, their involvement as an indicator alone and as a potential leverage point for 
drug research makes them widely researched molecules (Green 2000; Dudai et al. 2005). 
This protease has been implicated as an “effector” Caspase associated with the initiation 
of the “death cascade” and is therefore an important marker of the cells entry point into 
the apoptotic signalling pathway (Green 2000; Dudai et al. 2005). When apoptosis is acti-
vated, caspases cleave multiple protein substrates “en masse”, which leads to the loss of 
cellular structure and function, and ultimately results in cell death (Green 2000; Dudai et 
al. 2005). In particular, caspases -8, -9, and -3 have been implicated in apoptosis: caspa-
se-9 in the mitochondrial pathway, caspase-8 in the Fas/CD95 pathway, and caspase-3 
more downstream, activated by multiple pathways (Green 2000). As cleaved caspase 3 
was not observed in both cell lines tested (figure 3.3.1 A and B), the effector of the apop-
tosis (in this study) was not exhibited by other caspases and/or other proteins, concluding 
that apoptosis was not induced by EOs treatments. 
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Figure 4.5.1.1 - Downstream targets of the p53 transcription factor mediate its different biological 
outcome. The genes in p53 activated network initiate one of three programs that result in cell cycle 
arrest (G1 or G2 blocks are observed), cellular senescence or apoptosis. (Harris & Levine, 2005). 
 
In section 3.3, Seseli tortuosum EO treatment was tested by western blot carrying p53 - a 
tumor suppressor protein - and cleaved caspase 3 - responsible for programmed cell 
death/apoptosis signaling pathway. 
According to the results observed in section 3.3, Seseli tortuosum EO treatments of the 
MCF7 cell line lead to a stabilisation in p53 protein expression (figure 3.3.1 A and C). This 
suggests that p53 was activated by stress in cells, associated to engagement of apopto-
sis, cell cycle arrest or cellular senescence. Once cleaved caspase 3 (an indicator of 
apoptosis induction) was not observed in present results, apoptosis does not seem to be 
induced by treatments with Seseli tortuosum EO.   
Although caspase 3 is a precise effector of apoptosis, other methodologies that are used 
as apoptosis triggers could be used to confirm these results. These methodologies include 
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investigating any plasma membrane alterations (detecting early apoptosis markers), mito-
chondrial changes (in apoptosis mitochondrial membrane suffers permeability and soluble 
proteins such as cytochrome c and pro-caspases are release) or DNA fragmentation (last 
phase in apoptosis resulting from the activation of endonucleases during the apoptotic 
process).   
In the same western blot, Seseli tortuosum EO treatment was tested carrying p21 protein, 
which is relevant for study of cell cycle arrest (figure 3.3.1). 
The p21 expression was observed in Western blot analysis, in all times tested, except at 
48h in DMSO treatment. At 48h in EO treatment the level of p21 was very low. In 8h EO 
treatment and 72h DMSO treatment the level of area density were very high. The p21 was 
reported above (section 1.3.2) as a protein that interferes with the cell cycle, blocking it. 
When the transcription of the gene encoding p21 is stimulated by the transcription factor 
p53, p21 arrest the G1/S phase-CDK/cyclin and S phase-CDK/cyclin complexes and 
inhibits their activity, blocking the entry to the next stage of the cell cycle (figure 1.3.2.1). 
Treatment of RKO cells with Seseli tortuosum EO also led to a time-dependent increase in 
the protein levels of p53. These levels were more substantial than levels observed for 
MCF7 cells (figure 3.3.1 B and D). 
In its turn, in RKO cell line, decreased p21 protein levels were observed in treatment 2 
(EO at 8 hours), 3 (DMSO at 24h) and 7 (DMSO at 72 hours). Although an increase was 
shown for both treatments – DMSO and EO at 48 hours. Through this results, it is 
possible to deduce that a cell cycle arrest by stimulation of p21 was induced, since p53 
was activated. Protein p53 were accumulated at high levels and transcription of genes, 
including gene that encodes p21 protein, was stimulated (Figure 1.3.2.1). 
Otanthus maritimus EO treatment showed an increase of p53 protein expression levels 
(figure 3.3.2 A and C). The EOs treatments suggests that the protein amount had highest 
levels than DMSO treatments, except in 24 hours and 48 hours, which showed a slight 
decrease of these levels.  
A clear increase of p53 protein expression levels was displayed by treatments at 72 
hours, which was expected, as at 72 hours of incubation the confluence was very high 
before harvesting, comparing to the 8 hours of incubation. This indicates cellular stress in 
MCF7 cell line was induced, activating p53 protein. 
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An increase of p21 levels, as shown in figure 3.3.2 C, was observed until 72 hours - at this 
time, p21 was not observed. The levels of p21 amount suggests the EOs treatments were 
higher than DMSO treatments. This is what we expected because the confluence of 
MCF7 cells had an increase along times of incubation, before harvesting and preparation 
of cells for western blot. This suggests that a stress signal was transmitted to the p53 
protein by post-translational modifications, and by activating p21 these cells were induced 
to cell cycle arresting. 
In RKO cells (figure 3.3.1 B and D), it was observed that p53 had highest protein 
expression levels in all EO treatments, comparing to DMSO treatments. For the treatment 
2 (EO at 8 hours), 6 (EO at 48 hours) and 8 (EO at 72 hours) the levels of protein 
expression were very similar, ranging an area density from 1.85 and 2.10. DMSO 
treatments levels were included between 0.35 and 1. According to the results obtained, 
the EO treatments in all time points tested had a higher number of cells that transmitted 
stress signals, activating the tumour suppressor p53 protein. 
In the same cell line, p21 showed highest protein amount in Otanthus maritimus EO 
comparing to DMSO treatments, in every time point tested. The protein amount in EO at 
48 hours had a significant increase of p21. The increase of this protein is according to 
what was expected, as the confluence of the cells increased with the progress of time of 
incubation. Merely, the protein amount of p21 in EO at 72 hours should be higher. It can 
be stated, according to results in figure 3.3.2 D, that an induction of cellular stress has 
occurred, due to cell cycle arrested by stimulation of protein p21. 
 
4.5.2 Cell cycle analysis of Seseli tortuosum EO 
The presence of increased p21 protein expression levels was detected after all treatments 
performed. A cell cycle progression study was performed with the objective to determine 
any potential effect on Seseli tortuosum EO on cell cycle, by Fluorescence-activated cell 
sorting (FACS). This technique was selected because of numerous advantages, namely, 
allowing very high purity (95-100%) of the desired population, the target cell population 
expresses very low level of the identified marker, allows separation based on differential 
marker density, is the only available purification technique that isolate cells based in inter-
nal staining or intracellular protein expression, and allows the purification of individual 
cells based on size, granularity and fluorescence (Basu et al. 2010). 
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All cells in G1 phase have a uniform DNA content, as do cells in G2/M; the latter have 
twice as much DNA as G1 cells (figure 1.3.3.1). Under ideal conditions of DNA staining, 
the fluorescence intensities of all G1 or G2/M cells are expected to be uniform, and after 
analog-to-digital conversion of the electronic signal from the photomultiplier (representing 
their fluorescence intensity), to have uniform numerical values, respectively (Pozarowski & 
Darzynkiewicz 2004). In practice, however, the G1 and G2 cell populations are represented 
on frequency histograms by peaks of various widths (Pozarowski & Darzynkiewicz 2004).  
In RKO cell line samples treated with Seseli tortuosum EO, the DNA content histograms 
are shown in figure 3.3.3 and percentage of cells per stage of the cell cycle are 
represented in table V. According to results, the amount of cells in G1 phase (represented 
by M1) increased by the time of treatment. At 72 hours of EO treatment almost 58% of the 
cells were at G1 phase, instead, at 8 hours incubation with EO, 32% of the cells were at 
G1 phase indicating a potential cell cycle arrest in G1 phase. 
The successive increase by the time of incubation of the percentage of cells in S phase 
(represented by M2), which was not expected, may indicate that cells had some issue in 
intra-S checkpoint or DNA replication, possibly induced by of spontaneous chemical 
reactions in DNA, errors in DNA replication, or exposure to radiation or exogenous 
chemicals. At 48 hours of treatment the percentage of cells in S phase started to decrease 
indicating that cells had a possible cell cycle arrest in G1 phase. For 48 hours and 72 
hours treatment time points the results was what we expected because p21 was 
stimulated by p53 expression blocking the cell cycle arrest, possibly in G1 phase. 
However, at 24 hours of treatment the percentage of cells, in the same cell cycle phase (S 
phase), had an increase, which was not expected because at this time point, applying the 
principle, that cell cycle arrest occur in G1 phase, the percentage of cells in S phase 
should had a successive decrease. 
The number of cells in G2 phase (represented by M3), by the time of EO treatments, had a 
decrease of percentage of cells, what was expected, as the cell cycle arrest occurs in G1 
phase. This way, the percentage of cells in S and G2 phases should have had a decrease 
comparing to G1 phase. In Seseli tortuosum EO the decrease of percentage of cells was 
expected, indicating that cells in this phase were more sensitive, for example, to radiation, 
as preparation for synthesis of DNA, replication of DNA and cell growth were blocked. In 
DMSO treatments, the values (table V) of percentage of cells was has expected because 
if in G1 phase the cell cycle had an arrest, the other two phases (S and G2 phases) should 
had a decrease in their percentage of cells. The percentage of cells at 72 hours in DMSO 
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was not expected since had an increase in this treatment and this value should be lower 
than DMSO at 72 hours. 
In MCF7 samples with Seseli tortuosum EO treatment, the DNA content histograms are 
shown in figure 3.3.4 and percentage of cells per stage of the cell cycle are represented in 
table VI. 
According to results, the control treatment (figure 3.3.4 A and table VI) was not 
quantifiable. One possible explanation for this happening, was the presence of doublets. 
One problem that must be overcome when obtaining results for DNA analysis, by FACS, 
is the exclusion of aggregates of cells (Nunez 2001). On a flow cytometer, two cells 
together may register as a single event, known as a doublet. If each of those two cells is 
diploid (2N), seen as one event, they have 4N DNA (Nunez 2001). In other words, the 
cells appear to have the same amount of DNA as a single tetraploid cell (G0/G1), or the 
same amount as a cell that is about to enter mitosis (Nunez 2001). The doublet problem 
can be resolved by employing a doublet discrimination gate based on the characteristics 
of fluorescence height (FL2-H), fluorescence area (FL2-A) and signal width (FL2-W) 
(Wang et al. 2011). Fluorescence height is the maximum fluorescence given out by each 
cell as it travels through the laser beam; fluorescence area is the total amount of 
fluorescence emitted during the same journey; and signal width is the time a cell takes to 
pass through the laser beam (Wang et al. 2011; Nunez 2001). These characteristics are 
different for a cell that is about to enter mitosis when compared to two cells that are 
together. In mitosis the cell does not double its membrane and cytoplasmic size and, 
because of that, passes through the laser more quickly than two cells together (Nunez 
2001; Wang et al. 2011). Also, all of the DNA in the dividing cell is grouped together in 
one nucleus emitting a higher intensity of emitted fluorescence, compared with the DNA in 
two cells that are together (Nunez 2001; Wang et al. 2011). Thus, a doublet, which has 
two nuclei separated by cytoplasm, emits a lower intensity signal over a longer period. 
This appears as a higher signal width, lower signal height and the same area. These 
differences can be seen on histograms of FL2-Area vs. FL2-Width or FL2-Area vs FL2 
(Nunez 2001; Wang et al. 2011; Ochatt 2006). 
In the same cell line, MCF7, the G1 phase had an increase, by the time, of percentage of 
cells, which indicates that the cell cycle could be arrested in this phase, as expected. The 
stimulation of p21 was the protein responsible for the cell cycle block. This event will carry 
to the block of the DNA replication (that occurs in S phase of the cell cycle).  
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The decrease by the time of incubation of percentage of cells in S phase (represented by 
M2) was expected because p21 was stimulated by p53 expression blocking the cell cycle 
arrest, possibly in G1 phase. If the block of the cell cycle occurs in this phase, the 
percentage of cells in S and G2 phases will suffer a decrease (the DNA replication was 
compromised). In these results it is possible to observe that Seseli tortuosum EO 
treatment at 72 hours had an increase in the percentage of cells, which was not expected. 
As explained above, by the times points tested, EO treatment should have had a strong 
effect in cell cycle and, at this time point the percentage of cells in S phase, a decrease as 
DNA replication was been compromised. In this stage of the cell cycle, at 48 hours and 72 
hours for DMSO, the percentage of cells was very low, which may indicate the presence 
of doublets. 
In G2 phase, by the time points tested of EO treatments the percentage of cells had a 
decreased in both treatments (DMSO and Seseli tortuosum EO), as predicted. At 72 
hours, the percentage of cells was lower indicating the cells in this stage were more 
sensitive. This happened because DNA replication was compromised blocking the 
replication of cells in G1 phase of the cell cycle.  
Some mechanisms of action of EO field as anticancer agent have been suggested. Bhalla 
and colleagues suggested that various mechanisms such as antioxidant, antimutagenic 
and antiproliferative, enhancement of immune function and surveillance, enzyme induction 
and enhancing detoxification, modulation of multidrug resistance and synergistic 
mechanism of volatile constituents are responsible for their chemopreventive properties 
(Bahlla et al. 2013).  
Gautam and collaborators (Gautam et al. 2014) suggested that EOs, in general, with 
therapeutic potential can act by two ways - chemoprevention and cancer suppression. 
The various mechanisms proposed in cancer treatment (figure 4.5.2.1) are activation of 
detoxification enzymes, modulation of DNA repair signalling, antimetastasis, and 
antiangiogenesis. Multiple pathways are involved in the antiproliferative activity 
demonstrated by the EOs in the cancer cells and EOs are even effective in the reduction 
of tumours in animal models. This makes EOs potential suitable anticancer agents being 
displayed on the normal cells. 
One mechanism of action of EOs proposed by Gautam and colleagues was related with 
the expression of p21 and other negative regulators of cell cycle progression, blocking the 
cell cycle in different phases (Gautam et al. 2014). Treatment with patchouli alcohol, 
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which is an important component of Pogostemon cablin EO, has been reported to lead to 
an upregulation p21 expression and suppression of cyclin D1 and cyclin-dependent 
kinase 4 (CDK4) expression in colorectal cancer cells with increase in dose (Gautam et al. 
2014). 
As p21 is a negative regulator of G1 phase transition, increased expression of this protein 
by the action of patchouli alcohol is indicative of cell cycle inhibition (Gautam et al. 2014). 
Similar arrest of the G1 transition has also been reported in different types of cancer in 
response to various other EOs (Gautam et al. 2014). 
Treatment with EOs extracted from Curcuma wenyujin inhibits S/G2 phase transition, lead-
ing to cancer cell death (Gautam et al. 2014). G2/M phase transition arrest has been re-
ported on the treatment of liver tumour (J-5) cells with diallyl trisulfide, garlic EO constitu-
ents (Gautam et al. 2014). Various constituents like geraniol, thymol, and carvacrol of EOs 
inhibit different phases of cell cycle (Gautam et al. 2014). Monoterpenes act by altering 
the expression of cell cycle. Genes such DDIT3 (DNA-damage-inducible transcript 3), IL8 
(Interleukin 8), and CDKNIA (Cyclin-dependent kinase inhibitor 1A gene), which can mod-
ulate cell cycle arrest, have been reported to be upregulated by frankincense oil (Gautam 
et al. 2014). Therefore, EOs and their constituents can serve as effective anticancer sub-
stances by targeting cell cycle progression in cancer cells 
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Figure 4.5.2.1 - EOs and their constituents target multiple pathways in cancer cells. EOs by virtue 
have cell membrane permeability and act on different cellular targets involved in various pathways. 
EOs increase intracellular ROS/RNS levels which results in apoptosis in cancer cells. Inhibition of 
Akt, mTOR, and MAPK pathways at different steps by EOs leads to corresponding up-/down 
regulation of various key biomolecules (and corresponding genes which are not shown in the 
figure). Alteration in expression of NF-𝜅B by EOs and further binding of NF-𝜅B to DNA result in 
apoptosis in cancer cells. Dephosphorylation of Akt by the action of EOs results in overexpression 
of p21, which either induces apoptosis by increasing caspases level or results in cell cycle arrest by 
binding to cyclins. In addition, EOs-induced mitochondrial stress leads to activation of Bcl-2 and 
membrane depolarisation resulting in enhanced release of cytochrome-C to the cytoplasm which 
induces apoptotic cell death in cancer cells. EOs also modulate DNA repair mechanisms by acting 
as DNA polymerase inhibitors and led to PARP cleavage which also results in apoptosis in cancer 
cells (Gautam et al. 2014). 
 
Rezaei and colleagues reported that the pericarp methanolic extract of Pistacia atlantica 
sub kurdica (with local name of Baneh), as a rich source of active biological components 
with high antioxidant and radical scavenging activities, has ability to cease proliferation 
and induce apoptosis in T47D human breast cancer cells. This study aimed to clarify 
whether Baneh extract was able to alter cell cycle progression of T47D cells, and 
concluded that Baneh extract induced G0/G1 cell cycle arrest in conjunction with a marked 
decrease in expression of cyclin D1 and Cdk4 that was strongly dependent on time of 
exposure (Rezaei et al. 2012). 
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In nature, EOs play an important role in the protection of the plants as antibacterial, 
antiviral, antifungal, insecticides and also against herbivores by reducing their appetite for 
such plants. They also may attract some insects to favour pollination and seed dispersion 
EOs are as well very useful in the treatment of different diseases and their medicinal 
application has become very popular. 
In this study, every EOs tested showed a decrease in cellular viability/proliferation. When 
comparing the activity of the EOs extracted from the species selected for the present 
study, it is possible to conclude that Seseli tortuosum, Otanthus maritimus and Artemisia 
campestris subsp. maritima EOs revealed the highest efficacy in decreasing cellular 
viability, in MTS assay and noted by the low IC50 values, deserving further research to 
comprove this results and possibly, using this EOs in health applications.The other EOs – 
Crithmum maritimum, Juniperus turbinata subsp. turbinata and Eryngium maritimum – 
also showed a decrease in cellular viability, however, the IC50 values were higher. 
Eryngium maritimum EO was the only oil mix that induced a substantial increase in 
cellular viability, when tested at a starting concentration 5 µL/mL. The starting 
concentration 5 µL/mL revealed to be very toxic to the cell lines tested. 
A preliminary study of the mechanism of biological effect of the EOs, showed an increase 
of p53 protein in cells treated with Seseli tortuosum and Otanthus maritimus EO, pointing 
towards that the cellular stress was induced in the cells tested. Cleaved caspase 3 was 
not observed, indicating that apoptosis does not seem to be the cause of the decrease of 
cellular viability/proliferation. Other methods to test apoptosis induction should be used, 
for example, mitochondrial changes or DNA fragmentation. 
The expression of p21 had an increase after treatment with the described EOs, leading to 
the conclusion that EO treatment is associated with cell cycle arrest. Seseli tortuosum EO 
treatment, with FACS technique, showed the possibility of the cell cycle arrest could be 
happening in the G1 phase.  
It is important to continue this study to give further evidences to the present results. More 
inter-replicas, principally in MTS assay should be done, in order to reduce the variability of 
the data verified in IC50 values and the number of inter-replicas in EOs should be equals in 
order to a best comparison possible between every EOs. 
These results demonstrate the antiproliferation activity potential of the tested EOs from 
sand dune plants, and may consequently provide insight into the development of cancer 
research, and highlighting the importance for the preservation of dune systems. 
5. Conclusion and Future Work 
114 
The chemical profile of the tested EOs differ not only in the number of molecules but also 
in the relative amount of each compound. The chemical composition of the EOs can vary 
according to climate, soil composition, plant organ, age and vegetative cycle stage. So in 
order to obtain EOs of similar composition, they have to be extracted under the same 
conditions:  same organ of the plant which has been growing on the same soil, under the 
same climate and has been collected in the same season. In this sense, it would be 
interesting to test the variability of effects from different locations of the Portuguese coast, 
in flowering stage. It would be interesting to use different extraction methods of the EOs 
and compare the different percentages of the chemical compounds in species of the 
present study. 
In recent decades, EOs have been in increasing demand by manufacturers of foods, 
cosmetics and pharmaceuticals, hence the importance of conducting studies on EOs lies 
not only in their chemical characterization, but also in the possibility of linking the chemical 
contents with particular functional properties. In this regard, it is advisable to use methods 
for the assessment of biological activities that not only highlight aromatic or preservative 
activities, but also correlate with functional properties that might be potentially useful for 
pharmaceuticals, nutraceuticals and cosmetic applications.  
EOs have been shown to affect positively the immune system on a chemical level despite 
their direct effect on tumour cells. Possibly, the activity of the main components of the 
EOs is modulated by compounds in low amount. Moreover, it is probable that several 
components have a significant role in the fragrance, density, texture, colour and above all, 
cell penetration, lipophilic or hydrophilic attraction and fixation on cell walls and 
membranes, and cellular distribution. For this reason, separate molecules should also 
require some studies in order to evaluate their biological properties. For biological 
purposes, it is very important to evaluate the entire EO rather than some of its 
components, because usually the different compounds have a synergistic effect.  
Conventional chemotherapeutic agents used in cancer treatment are very toxic, therefore, 
the development of a new class of anticancer drugs that lack the toxicity of conventional 
chemotherapeutic agents and that are unaffected by common mechanisms of chemo 
resistance would be a major advance in cancer treatment. Bearing in mind this reality and 
the promising results here shown, further studies in order to better understand the 
mechanism of action of EOs in the decrease of cellular viability/proliferation should be 
addressed as it is of major concern to find novel potential drugs for cancer treatment.
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